CTR065198 MARICOPA FOR SIGNATURE (002).PDF
Extracted text (via pymupdf)
175943 characters
INTERGOVERNMENTAL AGREEMENT
(IGA)
Contract No. CTR065198
ARIZONA DEPARTMENT OF
HEALTH SERVICES
150 North 18th Avenue, Suite 530
Phoenix, Arizona 85007
Procurement Officer
Anthony Beckum
Page 1 of 23
Revised 3/24/2023
Project Title: Component C PrEP/PEP Navigation Services
Geographic Service Area: Maricopa County
Begin Date: January 1, 2024
Termination Date: December 31, 2029
Arizona Department of Health Services has authority to contract for services specified herein in accordance with A.R.S. §§ 11-951, 11-952, 36-
104 and 36-132. The Contractor represents that it has authority to contract for the performance of the services provided herein pursuant to:
X
Counties:
A.R.S. §§ 11-201, 11-951, 11-952 and 36-182.
Indian Tribes: A.R.S. §§ 11-951, 11-952 and the rules and sovereign authority of the contracting Indian
Nation.
School Districts: A.R.S. §§ 11-951, 11-952, and 15-342.
City of Phoenix: Chapter II, §§ 1 & 2, Charter, City of Phoenix.
Amendments signed by each of the parties and attached hereto are hereby adopted by reference as a part of this Contract, from the effective
date of the Amendment, as if fully set out herein.
Arizona Transaction (Sales) Privilege:
Federal Employer Identification No.:
Tax License No.:
Contractor Name: Maricopa County Department of Public
Health
Address: 4041 N. Central Ave., Suite 1400
Phoenix, AZ 85012
FOR CLARIFICATION, CONTACT:
Name: Issmene Delgado
Phone: 602-372-1485
FAX No:
E-mail: Issmene.Delgado@maricopa.gov
CONTRACTOR SIGNATURE:
The Contractor agrees to perform all the services set forth in the
Agreement and Work Statement.
This Contract shall henceforth be referred to as Contract
No. CTR065198 The Contractor is hereby cautioned not to commence
any billable work or provide any material, service or construction under this
Contract until Contractor receives a fully executed copy of the Contract.
Signature of Person Authorized to Sign Date
State of Arizona
Signed this
day of
, 202_
Print Name and Title
Procurement Officer
CONTRACTOR ATTORNEY SIGNATURE:
Pursuant to A.R.S. § 11-952, the undersigned Contractor’s
Attorney has determined that this Intergovernmental Agreement is
in proper form and is within the powers and authority granted under
the laws of Arizona.
Contract, No. CTR065198, is an Agreement between public agencies, has been
reviewed pursuant to A.R.S. § 11-952 by the undersigned Assistant Attorney
General, who has determined that it is in the proper form and is within the powers
granted under the laws of the State of Arizona to those parties to the Agreement
represented by the Attorney General.
The Attorney General, BY:
Signature
Date
Assistant Attorney General:
Signature of Person Authorized to Sign Date
Print Name and Title
CONTRACT NUMBER
INTERGOVERNMENTAL AGREEMENT
TERMS AND CONDITIONS
CTR065198
Page 2 of 23
Revised 3/24/2023
1.
Definition of Terms. As used in this Contract, the terms listed below are defined as follows:
As used in this Contract, the terms listed below are defined as follows:
1.1
“Attachment” means any item in the Contract which requires the Contractor to submit as part of the Offer.
1.2
“Contract” means the combination of the Contract documents, including the Terms and Conditions, and the
Specifications and Statement or Scope of Work; and any Contract Amendments.
1.3
"Contract Amendment" means a written document signed by the Procurement Officer that is issued for the
purpose of making changes in the Contract.
1.4
“Contractor” means any person who has a Contract with the State.
1.5
“Data” means recorded information, regardless of form or the media on which it may be recorded. The term
may include technical data and computer software. The term does not include information incidental to
contract administration, such as financial, administrative, cost or pricing, or management information.
1.6
“Days” means calendar days unless otherwise specified.
1.7
“Exhibit” means any item labeled as an Exhibit in the Contract generally containing maps, schematics,
examples of reports, or other documents that will be used to perform the requirements of the Scope of
Work after contract award.
1.8
“Gratuity” means a payment, loan, subscription, advance, deposit of money, services, or anything of more
than nominal value, present or promised, unless consideration of substantially equal or greater value is
received.
1.9
“Materials” means all property, including equipment, supplies, printing, insurance and leases of property but
does not include land, a permanent interest in land or real property or leasing space.
1.10 “Procurement Officer” means the person, or his or her designee, duly authorized by the State to enter into
and administer Contracts and make written determinations with respect to the Contract.
1.11 “Services” means the furnishing of labor, time or effort by a Contractor or Subcontractor which does not
involve the delivery of a specific end product other than required reports and performance, but does not
include employment agreements or collective bargaining agreements.
1.12 “State” means any department, commission, council, board, bureau, committee, institution, agency,
government corporation or other establishment or official of the executive branch or corporation commission
of the State of Arizona that executes the Contract.
1.13 “State Fiscal Year” means the period beginning with July 1 and ending June 30.
1.14 “Subcontract” means any Contract, express or implied, between the Contractor and another party or
between a Subcontractor and another party delegating or assigning, in whole or in part, the making or
furnishing of any Materials or any Services required for the performance of the Contract.
1.15 “Subcontractor” means a person who contracts to perform work or render Services to a Contractor or to
another Subcontractor as a part of a Contract with the State.
CONTRACT NUMBER
INTERGOVERNMENTAL AGREEMENT
TERMS AND CONDITIONS
CTR065198
Page 3 of 23
Revised 3/24/2023
2.
Contract Type.
This Contract shall be:
X
Cost Reimbursement
3.
Contract Interpretation
3.1.
Arizona Law. The Arizona law applies to this Contract including, where applicable, the Uniform
Commercial Code as adopted by the State of Arizona and the Arizona Procurement Code, Arizona
Revised Statutes (A.R.S.) Title 41, Chapter 23, and its implementing rules, Arizona Administrative Code
(A.A.C.) Title 2, Chapter 7.
3.2.
Implied Contract Terms. Each provision of law and any terms required by law to be in this Contract are
a part of this Contract as if fully stated in it.
3.3.
Contract Order of Precedence. In the event of a conflict in the provisions of the Contract, as accepted by
the State and as they may be amended, the following shall prevail in the order set forth below:
3.3.1.
Terms and Conditions
3.3.2.
Statement or Scope of Work;
3.3.3.
Specifications;
3.3.4.
Attachments;
3.3.5.
Exhibits; then
3.3.6.
Any other documents referenced or included in the Contract including, but not limited to, any
documents that do not fall into one of the above categories.
3.4.
Relationship of Parties. The Contractor under this Contract is an independent Contractor. Neither party
to this Contract shall be deemed to be the employee or agent of the other party to the Contract.
3.5.
Severability. The provisions of this Contract are severable. Any term or condition deemed illegal or
invalid shall not affect any other term or condition of the Contract.
3.6.
No Parole Evidence. This Contract is intended by the parties as a final and complete expression of their
agreement. No course of prior dealings between the parties and no usage of the trade shall supplement
or explain any terms used in this document and no other understanding either oral or in writing shall be
binding.
3.7.
No Waiver. Either party’s failure to insist on strict performance of any term or condition of the Contract
shall not be deemed a waiver of that term or condition even if the party accepting or acquiescing in the
nonconforming performance knows of the nature of the performance and fails to object to it.
4.
Contract Administration and Operation
4.1.
Term. As indicated on the signature page of the Contract, the Contract shall be effective as of the Begin
Date and shall remain effective until the Termination Date.
4.2.
Contract Renewal. This Contract shall not bind, nor purport to bind, the State for any contractual
commitment in excess of the original Contract period. The term of the Contract shall not exceed five (5)
years. However, if the original Contract period is for less than five (5) years, the State shall have the
right, at its sole option, to renew the Contract, so long as the original Contract period together with the
CONTRACT NUMBER
INTERGOVERNMENTAL AGREEMENT
TERMS AND CONDITIONS
CTR065198
Page 4 of 23
Revised 3/24/2023
renewal periods does not exceed five (5) years. If the State exercises such rights, all terms, conditions
and provisions of the original Contract shall remain the same and apply during the renewal period with
the exception of price and Scope of Work, which may be renegotiated.
4.3.
New Budget Term. If a budget term has been completed in a multi-term Contract, the parties may agree
to change the amount and type of funding to accommodate new circumstances in the next budget term.
Any increase or decrease in funding at the time of the new budget term shall coincide with a change in
the Scope of Work or change in cost of services as approved by the Arizona Department of Health
Services.
4.4.
Records. Under A.R.S. § 35-214 and § 35-215, the Contractor shall retain and shall contractually require
each Subcontractor to retain any and all Data and other “records” relating to the acquisition and
performance of the Contract for a period of five (5) years after the completion of the Contract. All records
shall be subject to inspection and audit by the State at reasonable times. Upon request, the Contractor
shall produce a legible copy of any or all such records.
4.5.
Non-Discrimination. The Contractor shall comply with State Executive Order No. 2023-01, 2009-09
and any and all other applicable Federal and State laws, rules and regulations, including the Americans
with Disabilities Act.
4.6.
Audit. Pursuant to A.R.S. § 35-214, at any time during the term of this Contract and five
(5) years thereafter, the Contractor’s or any Subcontractor’s books and records shall be subject to audit
by the State and, where applicable, the Federal Government, to the extent that the books and records
relate to the performance of the Contract or Subcontract.
4.7.
Facilities Inspection and Materials Testing. The Contractor agrees to permit access to its facilities,
Subcontractor facilities, and the Contractor’s processes or services, at reasonable times for inspection
of the facilities or Materials covered under this Contract as required under A.R.S. § 41-2547. The State
shall also have the right to test, at its own cost, the Materials to be supplied under this Contract. Neither
inspection of the Contractor’s facilities nor Materials testing shall constitute final acceptance of the
Materials or Services. If the State determines non-compliance of the Materials, the Contractor shall be
responsible for the payment of all costs incurred by the State for testing and inspection.
4.8.
Notices. Notices to the Contractor required by this Contract shall be made by the State to the person
indicated on the Offer and Acceptance form submitted by the Contractor unless otherwise stated in the
Contract. Notices to the State required by the Contract shall be made by the Contractor to the Solicitation
Contact Person indicated on the Solicitation, stated in the Contract, or listed on the State’s eProcurement
system. An authorized Procurement Officer and an authorized Contractor representative may change
their respective person to whom notice shall be given by written notice to the other and an amendment
to the Contract shall not be necessary.
4.9.
Advertising, Publishing and Promotion of Contract. The Contractor shall not use, advertise or promote
information for commercial benefit concerning this Contract without the prior written approval of the
Procurement Officer.
4.10.
Continuous Improvement. Contractor shall recommend continuous improvements on an on-going basis
in relation to any Materials and Services offered under the Contract, with a view to reducing State costs
and improving the quality and efficiency of the provision of Materials or Services. State may require
Contractor to engage in continuous improvements throughout the term of the Contract.
4.11.
Other Contractors. State may undertake on its own or award other contracts to the same or other
suppliers for additional or related work. In such cases, the Contractor shall cooperate fully with State
employees and such other suppliers and carefully coordinate, fit, connect, accommodate, adjust, or
sequence its work to the related work by others. Where the Contract requires handing-off Contractor’s
work to others, Contractor shall cooperate as State instructs regarding the necessary transfer of its work
product, Materials, Services, or records to State or the other suppliers. Contractor shall not commit or
permit any act that interferes with the State’s or other suppliers’ performance of their work, provided that,
CONTRACT NUMBER
INTERGOVERNMENTAL AGREEMENT
TERMS AND CONDITIONS
CTR065198
Page 5 of 23
Revised 3/24/2023
State shall enforce the foregoing section equitably among all its suppliers so as not impose an
unreasonable burden on any one of them.
4.12.
Ownership of Intellectual Property
4.12.1.
Rights In Work Product. All intellectual property originated or prepared by Contractor pursuant
to the Contract, including but not limited to, inventions, discoveries, intellectual copyrights,
trademarks, trade names, trade secrets, technical communications, records reports, computer
programs and other documentation or improvements thereto, including Contractor’s
administrative communications and records relating to the Contract, are considered work
product and Contractor’s property, provided that, State has Government Purpose Rights to
that work product as and when it was delivered to State.
4.12.2.
“Government Purpose Rights” are:
4.12.2.1.
the unlimited, perpetual, irrevocable, royalty free, non-exclusive, worldwide right
to use, modify, reproduce, release, perform, display, sublicense, disclose and
create derivatives from that work product without restriction for any activity in
which State is a party;
4.12.2.2.
the right to release or disclose that work product to third parties for any State
government purpose; and
4.12.2.3.
the right to authorize those to whom it rightfully releases or discloses that work
product to use, modify, release, create derivative works from the work product
for any State government purpose; such recipients being understood to include
the federal government, the governments of other states, and various local
governments.
4.12.3.
“Government Purpose Rights” do not include any right to use, modify, reproduce, perform,
release, display, create derivative works from or disclose that work product for any
commercial purpose, or to authorize others to do so.
4.12.4.
Joint Developments. The Contractor and State may each use equally any ideas, concepts,
know-how, or techniques developed jointly during the course of the Contract, and may do so
at their respective discretion, without obligation of notice or accounting to the other party.
4.12.5.
Pre-existing Material. All pre-existing software and other Materials developed or otherwise
obtained by or for Contractor or its affiliates independently of the Contract or applicable
Purchase Orders are not part of the work product to which rights are granted State under
subparagraph 3.9.1 above, and will remain the exclusive property of Contractor, provided
that:
4.12.5.1.
any derivative works of such pre-existing Materials or elements thereof that are
created pursuant to the Contract are part of that work product;
4.12.5.2.
any elements of derivative work of such pre-existing Materials that was not
created pursuant to the Contract are not part of that work product; and
4.12.5.3.
except as expressly stated otherwise, nothing in the Contract is to be construed
to interfere or diminish Contractor’s or its affiliates’ ownership of such pre-
existing Materials.
CONTRACT NUMBER
INTERGOVERNMENTAL AGREEMENT
TERMS AND CONDITIONS
CTR065198
Page 6 of 23
Revised 3/24/2023
4.12.6.
Developments Outside Of Contract. Unless expressly stated otherwise in the Contract, this
Section does not preclude Contractor from developing competing Materials outside the
Contract, irrespective of any similarity to Materials delivered or to be delivered to State
hereunder.
4.13.
Property of the State. If there are any materials that are not covered by Section 4.9 above created under
this Contract, including but not limited to, reports and other deliverables, these materials are the sole
property of the State. The Contractor is not entitled to a patent or copyright on those materials and may
not transfer the patent or copyright to anyone else. The Contractor shall not use or release these
materials without the prior written consent of the State.
4.14.
Federal Immigration and Nationality Act. Contractor shall comply with all federal, state and local
immigration laws and regulations relating to the immigration status of their employees during the term of
the contract. Further, Contractor shall flow down this requirement to all Subcontractors utilized during
the term of the contract. The State shall retain the right to perform random audits of Contractor and
Subcontractor records or to inspect papers of any employee thereof to ensure compliance. Should
the State determine that the Contractor or any Subcontractors be found noncompliant, the State may
pursue all remedies allowed by law, including, but not limited to: suspension of work, termination of the
contract for default and suspension or debarment of the contractor.
4.15.
E-Verify Requirements. In accordance with A.R.S. § 41-4401, Contractor warrants compliance with all
Federal immigration laws and regulations relating to employees and warrants its compliance with Section
A.R.S. § 23- 214, Subsection A.
4.16.
Offshore Performance of Work involving Data is Prohibited. Any Services that are described in the
specifications or scope of work that directly serve the State of Arizona or its clients and involve access
to Data shall be performed within the defined territories of the United States.
4.17.
Certifications Required by State Law.
4.17.1.
If Contractor is a Company as defined in A.R.S. § 35-393, Contractor certifies that it is
not currently engaged in a boycott of Israel as described in A.R.S. §§ 35-393 et seq. and
will refrain from any such boycott for the duration of this Contract.
4.17.2.
Contractor further certifies that it shall comply with A.R.S. § 35-394, regarding use of the
forced labor of ethnic Uyghurs, as applicable.
5.
Costs and Payments
5.1.
Payments. Payments shall comply with the requirements of A.R.S. Titles 35 and 41, Net 30 days. Upon
receipt and acceptance of Materials or Services, the Contractor shall submit a complete and accurate
invoice for payment from the State within thirty (30) days.
5.2.
Delivery. Unless stated otherwise in the Contract, per A.R.S. § 47-2319, all prices shall be F.O.B. (“free
on board”) Destination and shall include all freight delivery and unloading at the destination.
5.3.
Firm, Fixed Price. Unless stated otherwise in the Special Terms and Conditions of the Contract, all prices
shall be firm-fixed-prices.
5.4.
Applicable Taxes
5.4.1.
Payment of Taxes. The Contractor shall be responsible for paying all applicable taxes.
5.4.2.
State and Local Transaction Privilege Taxes. The State of Arizona is subject to all applicable
state and local transaction privilege taxes. Transaction privilege taxes apply to the sale and
are the responsibility of the seller to remit. Failure to collect such taxes from the buyer does
not relieve the seller from its obligation to remit taxes.
CONTRACT NUMBER
INTERGOVERNMENTAL AGREEMENT
TERMS AND CONDITIONS
CTR065198
Page 7 of 23
Revised 3/24/2023
5.4.3.
Tax Indemnification. Contractor and all Subcontractors shall pay all Federal, state and local
taxes applicable to its operation and any persons employed by the Contractor. Contractor
shall, and require all Subcontractors to hold the State harmless from any responsibility for
taxes, damages and interest, if applicable, contributions required under Federal, and/or state
and local laws and regulations and any other costs including transaction privilege taxes,
unemployment compensation insurance, Social Security and Worker’s Compensation.
5.4.4.
IRS W9 Form. In order to receive payment the Contractor shall have a current
I.R.S. W9 Form on file with the State of Arizona, unless not required by law.
5.5.
Availability of Funds for the Next State Fiscal Year. Funds may not presently be available for performance
under this Contract beyond the current State Fiscal Year. No legal liability on the part of the State for
any payment may arise under this Contract beyond the current State Fiscal Year until funds are made
available for performance of this Contract.
5.6.
Availability of Funds for the Current State Fiscal Year. Should the State Legislature enter back into
session and reduce the appropriations or for any reason and these Materials or Services are not funded,
the State may take any of the following actions:
5.6.1.
Accept a decrease in price offered by the Contractor;
5.6.2.
Cancel the Contract; or
5.6.3.
Cancel the Contract and re-solicit the requirements.
6.
Contract Changes
6.1.
Amendments. This Contract is issued under the authority of the Procurement Officer who signed this
Contract. The Contract may be modified only through a Contract Amendment within the scope of the
Contract. Changes to the Contract, including the addition of Services or Materials, the revision of
payment terms, or the substitution of Services or Materials, directed by a person who is not specifically
authorized by the Procurement Officer in writing or made unilaterally by the Contractor are violations of
the Contract and of applicable law. Such changes, including unauthorized written Contract Amendments
shall be void and without effect, and the Contractor shall not be entitled to any claim under this Contract
based on those changes.
6.2.
Subcontracts. The Contractor shall not enter into any Subcontract under this Contract for the
performance of this Contract without the advance written approval of the Procurement Officer as
described in Arizona State Procurement Office Standard Procedure 002. The Contractor shall clearly list
any proposed Subcontractors and the Subcontractor’s proposed responsibilities. The Subcontract shall
incorporate by reference the terms and conditions of this Contract.
6.3.
Assignment and Delegation. The Contractor shall not assign any right nor delegate any duty under this
Contract without the prior written approval of the Procurement Officer. The State shall not unreasonably
withhold approval.
7.
Risk and Liability
7.1.
Risk of Loss. The Contractor shall bear all loss of conforming Materials covered under this Contract until
received by authorized personnel at the location designated in the purchase order or Contract. Mere
receipt does not constitute final acceptance. The risk of loss for nonconforming Materials shall remain
with the Contractor regardless of receipt.
7.2.
Indemnification
CONTRACT NUMBER
INTERGOVERNMENTAL AGREEMENT
TERMS AND CONDITIONS
CTR065198
Page 8 of 23
Revised 3/24/2023
7.2.1.
Contractor/Vendor Indemnification (Not Public Agency).To the fullest extent permitted by law,
Contractor shall defend, indemnify, and hold harmless the State of Arizona, and its
departments, agencies, boards, commissions, universities, officers, officials, agents, and
employees (hereinafter referred to as “Indemnitee”) from and against any and all claims,
actions, liabilities, damages, losses, or expenses (including court costs, attorneys’ fees, and
costs of claim processing, investigation and litigation) (hereinafter referred to as “Claims”) for
bodily injury or personal injury (including death), or loss or damage to tangible or intangible
property caused, or alleged to be caused, in whole or in part, by the negligent or willful acts or
omissions of Contractor or any of its owners, officers, directors, agents, employees or
Subcontractors. This indemnity includes any claim or amount arising out of, or recovered
under, the Workers’ Compensation Law or arising out of the failure of such Contractor to
conform to any federal, state, or local law, statute, ordinance, rule, regulation, or court decree.
It is the specific intention of the parties that the Indemnitee shall, in all instances, except for
Claims arising solely from the negligent or willful acts or omissions of the Indemnitee, be
indemnified by Contractor from and against any and all claims. It is agreed that Contractor will
be responsible for primary loss investigation, defense, and judgment costs where this
indemnification is applicable. In consideration of the award of this contract, the Contractor
agrees to waive all rights of subrogation Insurance and Indemnification Guidelines for State
of Arizona Contracts Professional Service Contracts against the State of Arizona, its officers,
officials, agents, and employees for losses arising from the work performed by the Contractor
for the State of Arizona. This indemnity shall not apply if the Contractor or Subcontractor(s)
is/are an agency, board, commission or university of the State of Arizona.
7.2.2.
Public Agency Language Only. Each party (as 'indemnitor') agrees to indemnify, defend, and
hold harmless the other party (as 'indemnitee') from and against any and all claims, losses,
liability, costs, or expenses (including reasonable attorney's fees) (hereinafter collectively
referred to as 'claims') arising out of bodily injury of any person (including death) or property
damage but only to the extent that such claims which result in vicarious/derivative liability to
the indemnitee, are caused by the act, omission, negligence, misconduct, or other fault of the
indemnitor, its officers, officials, agents, employees, or volunteers.
7.3.
Indemnification - Patent and Copyright. The Contractor shall indemnify and hold harmless the State
against any liability, including costs and expenses, for infringement of any patent, trademark or copyright
arising out of Contract performance or use by the State of Materials furnished or work performed under
this Contract. The State shall reasonably notify the Contractor of any claim for which it may be liable
under this paragraph. If the Contractor is insured pursuant to A.R.S. § 41-621 and § 35-154, this
paragraph shall not apply.
7.4.
Force Majeure.
7.4.1.
Except for payment of sums due, neither the Contractor nor State shall be liable to the other
nor deemed in default under this Contract if and to the extent that such party’s performance of
this Contract is prevented by reason of force majeure. The term “force majeure” means an
occurrence that is beyond the control of the party affected and occurs without its fault or
negligence. Without limiting the foregoing, force majeure includes: acts of God, acts of the
public enemy, war, riots, strikes, mobilization, labor disputes, civil disorders, fire, flood,
lockouts, injunctions-intervention-acts, failures or refusals to act by government authority, and
other similar occurrences beyond the control of the party declaring force majeure which such
party is unable to prevent by exercising reasonable diligence.
7.4.2.
Force Majeure shall not include the following occurrences:
7.4.2.1.
Late delivery of equipment, Materials, or Services caused by congestion at a
manufacturer’s plant or elsewhere, or an oversold condition of the market;
7.4.2.2.
Late performance by a Subcontractor unless the delay arises out of a force
CONTRACT NUMBER
INTERGOVERNMENTAL AGREEMENT
TERMS AND CONDITIONS
CTR065198
Page 9 of 23
Revised 3/24/2023
majeure occurrence in accordance with this force majeure term and condition;
or
7.4.2.3.
Inability of either the Contractor or any Subcontractor to acquire or maintain any
required insurance, bonds, licenses or permits.
7.4.3.
If either the Contractor or State is delayed at any time in the progress of the work by force
majeure, the delayed party shall notify the other party in writing of such delay, as soon as is
practicable and no later than the following working day, of the commencement thereof and
shall specify the causes of such delay in such notice. Such notice shall be delivered or mailed
certified-return receipt and shall make a specific reference to this article, thereby
invoking its provisions. The delayed party shall cause such delay to cease as soon as
practicable and shall notify the other party in writing when it has done so. The time of
completion shall be extended by Contract Amendment for a period of time equal to the time
that results or effects of such delay prevent the delayed party from performing in accordance
with this Contract.
7.4.4.
Any delay or failure in performance by either party hereto shall not constitute default hereunder
or give rise to any claim for damages or loss of anticipated profits if, and to the extent that such
delay or failure is caused by force majeure.
7.5.
Third Party Antitrust Violations. The Contractor assigns to the State any claim for overcharges resulting
from antitrust violations to the extent that those violations concern Materials or Services supplied by third
parties to the Contractor, toward fulfillment of this Contract.
8.
Warranties
8.1.
Liens. The Contractor warrants that the Materials supplied under this Contract are free of liens and shall
remain free of liens.
8.2.
Quality. Unless otherwise modified elsewhere in the Terms and Conditions, the Contractor warrants that,
for one (1) year after acceptance by the State of the Materials, they shall be:
8.2.1.
Of a quality to pass without objection in the trade under the Contract description;
8.2.2.
Fit for the intended purposes for which the Materials are used;
8.2.3.
Within the variations permitted by the Contract and are of even kind, quantity, and quality
within each unit and among all units;
8.2.4.
Adequately contained, packaged, and marked as the Contract may require; and
8.2.5.
Conform to the written promises or affirmations of fact made by the Contractor.
8.3.
Conformity to Requirements.
8.3.1.
Contractor warrants that, unless expressly provided otherwise elsewhere in the Contract, the
Materials and Services will for one (1) year after acceptance and in each instance:
8.3.1.1.
Conform to the requirements of the Contract, which by way of reminder include
without limitation all descriptions, specifications, and drawings identified in the
Scope of Work and any and all Contractor affirmations included as part of the
Contract;
8.3.1.2.
Be free from defects of material and workmanship;
CONTRACT NUMBER
INTERGOVERNMENTAL AGREEMENT
TERMS AND CONDITIONS
CTR065198
Page 10 of 23
Revised 3/24/2023
8.3.1.3.
Conform to or perform in a manner consistent with current industry standards;
and
8.3.1.4.
Be fit for the intended purpose or use described in the Contract.
8.3.2.
Mere delivery or performance does not substitute for express acceptance by the State. Where
inspection, testing, or other acceptance assessment of Materials or Services cannot be done
until after installation or invoicing, the forgoing warranty will not begin until State’s explicit
acceptance of the Materials or Services.
8.4.
Inspection/Testing. The warranties set forth in this Section 8 [Warranties] are not affected by inspection
or testing of or payment for the Materials or Services by the State.
8.5.
Contractor Personnel. Contractor warrants that its personnel will perform their duties under the Contract
in a professional manner, applying the requisite skills and knowledge, consistent with industry standards,
and in accordance with the requirements of the Contract. Contractor further warrants that its key
personnel will maintain any and all certifications relevant to their work, and Contractor shall provide
individual evidence of certification to State’s authorized representatives upon request.
8.6.
Compliance With Applicable Laws. The Materials and Services supplied under this Contract shall comply
with all applicable federal, state, and local laws and policies (including, but not limited to, information
technology policies, standards, and procedures available on the State’s website and/or the website of
any department, commission, council, board, bureau, committee, institution, agency, government
corporation or other establishment or official of the executive branch or corporation commission of the
State of Arizona). Federal requirements may be incorporated into this Contract, if required, pursuant to
A.R.S. § 41-2637. Contractor shall maintain any and all applicable license and permit requirements. This
requirement includes, but is not limited to, any and all Arizona state statutes that impact state contracts,
regardless of whether those statutory references have been removed during the course of contract
negotiations; this is notice to Contractors that the State does not have the authority to modify Arizona
state law by contract.
8.7.
Intellectual Property. Contractor warrants that the Materials and Services do not and will not infringe or
violate any patent, trademark, copyright, trade secret, or other intellectual property rights or laws, except
only to the extent the Specifications do not permit use of any other product and Contractor is not and
cannot reasonably be expected to be aware of the infringement or violation.
8.8.
Licenses and Permits. Contractor warrants that it will maintain all licenses required to fully perform its
duties under the Contract and all required permits valid and in force.
8.9.
Operational Continuity. Contractor warrants that it will perform without relief notwithstanding being sold
or acquired; no such event will operate to mitigate or alter any of Contractor’s duties hereunder
absent a consented delegation under paragraph 5.3 [Assignment and Delegation] that expressly
recognizes the event.
8.10.
Performance in Public Health Emergency. Contractor warrants that it will:
8.10.1.
Have in effect, promptly after commencement, a plan for continuing performance in the
event of a declared public health emergency that addresses, at a minimum:
8.10.1.1.
Identification of response personnel by name;
8.10.1.2.
Key succession and performance responses in the event of sudden and
significant decrease in workforce; and
8.10.1.3.
Alternative avenues to keep sufficient product on hand or in the supply chain.
CONTRACT NUMBER
INTERGOVERNMENTAL AGREEMENT
TERMS AND CONDITIONS
CTR065198
Page 11 of 23
Revised 3/24/2023
8.10.2.
Provide a copy of its current plan to State within three (3) business days after State’s written
request. If Contractor claims relief under paragraph 7.4 [Force Majeure] for an occurrence
of force majeure that is a declared public health emergency, then that relief will be
conditioned on Contractor having first implemented its plan and exhausted all reasonable
opportunity for that plan implementation to overcome the effects of that occurrence, or
mitigate those effects to the extent that overcoming entirely is not practicable.
8.10.3.
A request from the State related to this paragraph 8.10 does not necessarily indicate that
there has been an occurrence of force majeure, and the Contractor will not be entitled to
any additional compensation or extension of time by virtue of having to implement a plan.
8.10.4.
Failure to have or implement an appropriate plan will be a material breach of contract.
8.11.
Lobbying
8.11.1.
Prohibition. Contractor warrants that it will not engage in lobbying activities, as defined in
40 Code of Federal Regulations (CFR) part 34 and A.R.S. § 41-1231, et seq., using monies
awarded under the Contract, provided that, the foregoing does not intend to constrain
Contractor's use of its own monies or property, including without limitation any net proceeds
duly realized under the Contract or any value thereafter derived from those proceeds; and
upon award of the Contract, it will disclose all lobbying activities to State to the extent they
are an actual or potential conflict of interest or where such activities could create an
appearance of impropriety. Contractor shall implement and maintain adequate controls to
assure compliance with above. Contractor shall obtain an equivalent warranty from all
Subcontractors and shall include an equivalent no-lobbying provision in all Subcontracts.
8.11.2.
Exception. This paragraph 8.11 does not apply to the extent that the Services are defined
in the Contract as being lobbying for State’s benefit or on State’s behalf.
8.12.
Covered Telecommunications or Services. Contractor warrants that the Materials and Services rendered
under this Agreement will not require Contractor to use for the State, or provide to the State to use,
"covered telecommunications equipment or Services" as a substantial or essential component of any
system, or as critical technology as part of any system, within the meaning of Federal Acquisition
Regulation (“FAR”) Section 52.204-25.
8.13.
Debarment, Suspension, U.S. Government Restricted Party Lists. Contractor warrants that it is not, and
its Subcontractors are not, on the U.S. government’s Denied Parties List, the Unverified List, the Entities
List, the Specially Designated Nationals and Blocked Parties List, and neither the Contractor nor any
Subcontractors are presently debarred, suspended, proposed for debarment or otherwise declared
ineligible for award of federal contracts or participation in federal assistance programs or activities.
8.14.
False Statements. Contractor represents and warrants that all statements and information Contractor
prepared and submitted in response to the Solicitation or as part of the Contract documents are current,
complete, true, and accurate. If the Procurement Officer determines that Contractor submitted an Offer
or Bid with a false statement, or makes material misrepresentations during the performance of the
Contract, the Procurement Officer may determine that Contractor has materially breached the Contract
and may void the submitted Offer or Bid and any resulting Contract.
8.15.
Survival of Rights and Obligations after Contract Expiration or Termination.
8.15.1.
Survival of Warranty. All representations and warranties made by Contractor under the
Contract will survive the expiration or earlier termination of the Contract.
8.15.2.
Contractor's Representations and Warranties. All representations and warranties made by
the Contractor under this Contract shall survive the expiration or termination hereof. In
addition, the parties hereto acknowledge that pursuant to A.R.S. § 12-510, except as
CONTRACT NUMBER
INTERGOVERNMENTAL AGREEMENT
TERMS AND CONDITIONS
CTR065198
Page 12 of 23
Revised 3/24/2023
provided in A.R.S. § 12- 529, the State is not subject to or barred by any limitations of actions
prescribed in A.R.S., Title 12, Chapter 5.
8.15.3.
Purchase Orders. The Contractor shall, in accordance with all terms and conditions of the
Contract, fully perform and shall be obligated to comply with all purchase orders received by
the Contractor prior to the expiration or termination hereof, unless otherwise directed in
writing by the Procurement Officer, including, without limitation, all purchase orders received
prior to but not fully performed and satisfied at the expiration or termination of this Contract.
9.
State's Contractual Remedies
9.1.
Right to Assurance. If the State in good faith has reason to believe that the Contractor does not intend
to, or is unable to perform or continue performing under this Contract, the Procurement Officer may
demand in writing that the Contractor give a written assurance of intent to perform. Failure by the
Contractor to provide written assurance within the number of Days specified in the demand may, at the
State’s option, be the basis for terminating the Contract under the Uniform Terms and Conditions or
other rights and remedies available by law or provided by the contract.
9.2.
Stop Work Order.
9.2.1.
The State may, at any time, by written order to the Contractor, require the Contractor to stop
all or any part of the work called for by this Contract for period(s) of days indicated by the State
after the order is delivered to the Contractor. The order shall be specifically identified as a stop
work order issued under this clause. Upon receipt of the order, the Contractor shall
immediately comply with its terms and take all reasonable steps to minimize the incurrence of
costs allocable to the work covered by the order during the period of work stoppage.
9.2.2.
If a stop work order issued under this clause is canceled or the period of the order or any
extension expires, the Contractor shall resume work. The Procurement Officer shall make an
equitable adjustment in the delivery schedule or Contract price, or both, and the Contract shall
be amended in writing accordingly.
9.3.
Non-exclusive Remedies. The rights and the remedies of the State under this Contract are not exclusive.
9.4.
Nonconforming Tender. Materials or Services supplied under this Contract shall fully comply with the
Contract. The delivery of Materials or Services or a portion of the Materials or Services that do not fully
comply constitutes a breach of contract. On delivery of nonconforming Materials or Services, the State
may terminate the Contract for default under applicable termination clauses in the Contract, exercise
any of its rights and remedies under the Uniform Commercial Code, or pursue any other right or remedy
available to it.
9.5.
Right of Offset. The State shall be entitled to offset against any sums due the Contractor, any expenses
or costs incurred by the State, or damages assessed by the State concerning the Contractor’s non-
conforming performance or failure to perform the Contract, including expenses, costs and damages
described in the Uniform Terms and Conditions.
10.
Contract Termination
10.1.
Cancellation for Conflict of Interest. Pursuant to A.R.S. § 38-511, the State may cancel this Contract
within three (3) years after Contract execution without penalty or further obligation if any person
significantly involved in initiating, negotiating, securing, drafting or creating the Contract on behalf of the
State is or becomes at any time while the Contract or an extension of the Contract is in effect an
employee of or a consultant to any other party to this Contract with respect to the subject matter of the
Contract. The cancellation shall be effective when the Contractor receives written notice of the
cancellation unless the notice specifies a later time. If the Contractor is a political subdivision of the
State, it may also cancel this Contract as provided in A.R.S. § 38-511.
CONTRACT NUMBER
INTERGOVERNMENTAL AGREEMENT
TERMS AND CONDITIONS
CTR065198
Page 13 of 23
Revised 3/24/2023
10.2.
Gratuities. The State may, by written notice, terminate this Contract, in whole or in part, if the State
determines that employment or a Gratuity was offered or made by the Contractor or a representative of
the Contractor to any officer or employee of the State with the purpose of influencing the outcome of the
procurement or securing the Contract, an amendment to the Contract, or favorable treatment concerning
the Contract, including the making of any determination or decision about contract performance. The
State, in addition to any other rights or remedies, shall be entitled to recover exemplary damages in the
amount of three (3) times the value of the Gratuity offered by the Contractor.
10.3.
Suspension or Debarment. The State may, by written notice to the Contractor, immediately terminate
this Contract if the State determines that the Contractor has been debarred, suspended or otherwise
lawfully prohibited from participating in any public procurement activity, including but not limited to, being
disapproved as a Subcontractor of any public procurement unit or other governmental body. Submittal
of an offer or execution of a contract shall attest that the Contractor is not currently suspended or
debarred. If the Contractor becomes suspended or debarred, the Contractor shall immediately notify the
State.
10.4.
Termination for Convenience. The State reserves the right to terminate the Contract, in whole or in part
at any time when in the best interest of the State, without penalty or recourse. Upon receipt of the written
notice, the Contractor shall stop all work, as directed in the notice, notify all Subcontractors of the
effective date of the termination and minimize all further costs to the State. In the event of termination
under this paragraph, all documents, Data and reports prepared by the Contractor under the Contract
shall become the property of and be delivered to the State upon demand. The Contractor shall be entitled
to receive just and equitable compensation for work in progress, work completed, and Materials or
Services accepted before the effective date of the termination. The cost principles and procedures
provided in A.R.S. § 41-2543 and A.A.C. Title 2, Chapter 7, Article 7, shall apply.
10.5.
Termination for Default.
10.5.1.
In addition to the rights reserved in the contract, the State may terminate the Contract in whole
or in part due to the failure of the Contractor to comply with any term or condition of the
Contract, to acquire and maintain all required insurance policies, bonds, licenses and permits,
or to make satisfactory progress in performing the Contract. The Procurement Officer shall
provide written notice of the termination and the reasons for it to the Contractor.
10.5.2.
Upon termination under this paragraph, all goods, Materials, documents, Data, and reports
prepared by the Contractor under the Contract shall become the property of and be delivered
to the State on demand.
10.5.3.
The State may, upon termination of this Contract, procure, on terms and in the manner that it
deems appropriate, Materials or Services to replace those under this Contract. The Contractor
shall be liable to the State for any excess costs incurred by the State in procuring Materials or
Services in substitution for those due from the Contractor.
10.6.
Continuation of Performance Through Termination. The Contractor shall continue to perform, in
accordance with the requirements of the Contract, up to the date of termination, as directed in the
termination notice.
11.
Contract Claims
All contract claims or controversies under this Contract shall be resolved according to A.R.S. Title 41, Chapter 23,
Article 9, and rules adopted thereunder.
12.
Arbitration
CONTRACT NUMBER
INTERGOVERNMENTAL AGREEMENT
TERMS AND CONDITIONS
CTR065198
Page 14 of 23
Revised 3/24/2023
The parties to this Contract agree to resolve all disputes arising out of or relating to this Contract through arbitration,
after exhausting applicable administrative review, to the extent required by A.R.S. § 12-1518, except as may be
required by other applicable statutes (A.R.S. Title 41).
13.
Communication
13.1.
Program Report. When reports are required by the Contract, the Contractor shall provide them in the format
approved by ADHS.
13.2.
Information and Coordination. The State will provide information to the Contractor pertaining to activities that
affect the Contractor’s delivery of services, and the Contractor shall be responsible for coordinating their
activities with the State’s in such a manner as not to conflict or unnecessarily duplicate the State’s activities.
As the work of the Contractor progresses, advice and information on matters covered by the Contract shall
be made available by the Contractor to the State throughout the effective period of the Contract.
14.
Client Grievances
If applicable, the Contractor and its subcontractors shall use a procedure through which clients may present
grievances about the operation of the program that result in the denial, suspension or reduction of services provided
pursuant to this Contract and which is acceptable to and approved by the State.
15.
Sovereign Immunity
Pursuant to A.R.S. § 41-621(O), the obtaining of insurance by the State shall not be a waiver of any sovereign
immunity defense in the event of suit.
16.
Administrative Changes
The Procurement Officer, or authorized designee, reserves the right to correct any obvious clerical, typographical or
grammatical errors, as well as errors in party contact information (collectively, “Administrative Changes”), prior to or
after the final execution of a Contract or Contract Amendment. Administrative Changes subject to permissible
corrections include: misspellings, grammar errors, incorrect addresses, incorrect Contract Amendment numbers,
pagination and citation errors, mistakes in the labeling of the rate as either extended or unit, and calendar date errors
that are illogical due to typographical error. The Procurement Office shall subsequently send to the Contractor notice
of corrections to administrative errors in a written confirmation letter with a copy of the corrected Administrative
Change attached.
17.
Health Insurance Portability and Accountability Act of 1996 (HIPAA)
17.1.
The Contractor warrants that it is familiar with the requirements of HIPAA, as amended by the Health
Information Technology for Economic and Clinical Health Act (HITECH Act) of 2009, and accompanying
regulations and will comply with all applicable HIPAA requirements in the course of this Contract. Contractor
warrants that it will cooperate with the Arizona Department of Health Services (ADHS) in the course of
performance of the Contract so that both ADHS and Contractor will be in compliance with HIPAA, including
cooperation and coordination with the Arizona Department of Administration-Arizona Strategic Enterprise
Technology (ADOA-ASET) Office, the ADOA-ASET Arizona State Chief Information Security Officer and
HIPAA Coordinator and other compliance officials required by HIPAA and its regulations. Contractor will
sign any documents that are reasonably necessary to keep ADHS and Contractor in compliance with HIPAA,
including, but not limited to, business associate agreements.
17.2.
If requested by the ADHS Procurement Office, Contractor agrees to sign a “Pledge To Protect Confidential
Information” and to abide by the statements addressing the creation, use and disclosure of confidential
information, including information designated as protected health information and all other confidential or
sensitive information as defined in policy. In addition, if requested, Contractor agrees to attend or participate
in HIPAA training offered by ADHS or to provide written verification that the Contractor has attended or
participated in job related HIPAA training that is: (1) intended to make the Contractor proficient in HIPAA for
CONTRACT NUMBER
INTERGOVERNMENTAL AGREEMENT
TERMS AND CONDITIONS
CTR065198
Page 15 of 23
Revised 3/24/2023
purposes of performing the services required and (2) presented by a HIPAA Privacy Officer or other person
or program knowledgeable and experienced in HIPAA and who has been approved by the ADOA-ASET
Arizona State Chief Information Security Officer and HIPAA Coordinator.
18.
Fraud, Waste, or Abuse
18.1.
ADHS requires all employees to abide by the State’s Personnel System Rules, R2-5A-501; Standards of
Conduct which includes maintaining high standards of honesty, integrity, and impartiality, free from personal
considerations and/or favoritism, and Code of Conduct for individuals engaged in Accounting, Financial and
Budgeting Activities which depicts the moral, ethical, legal and professional aspects of personal conduct.
ADHS requires the same conduct of its consultants, vendors, contractors, subrecipients, or persons doing
business with the agency.
18.2.
Any State employee, consultant, vendor, contractor or subrecipient or person doing business with the
Agency who receives a report of improper activity must report the information within one (1) business day.
Note: Federal Award policy denotes awardees must disclose, in a timely manner, in writing to ADHS all
violations of Federal Criminal Law, involving fraud, bribery, or gratuity violations potentially affecting Federal
Awards.
18.3. Anyone suspecting Fraud, Waste, or Abuse related to ADHS activities are required to report Fraud,
Waste, or abuse through any of the following reporting channels:
18.3.1. ADHS Ethics Action Hotline at (602) 542-2347,
18.3.2. ADHS Ethics Action Email at reportethics@azdhs.gov ,or
18.3.3. General Accounting Office (GAO) Fraud Reporting Email at reportfraud@azdoa.gov to report
Fraud, Waste, or Abuse incidents.
19.
Unique Entity Identifier (UEI) Requirement
Pursuant to 2 CFR 25.100 et seq., no entity (defined as a Governmental organization, which is a State, local
government, or Indian tribe; foreign public entity; domestic or foreign nonprofit organization; domestic or foreign for-
profit organization; or Federal agency, but only as a sub-recipient under an award or sub-award to a non-Federal
entity) may receive a sub-award from ADHS unless the entity provides its Unique Entity Identifier Number to ADHS.
The number can be created in SAM.gov. If already registered the UEI has been assigned and can be viewed in
SAM.gov .
20.
The Federal Funding Accountability and Transparency Act (FFATA or Transparency Act - P.L.109-282, as
amended by section 6202(a) of P.L. 110-252), found at https://www.fsrs.gov/
If applicable, the subrecipient or sub-awardee is required to abide by the Federal Funding Accountability and
Transparency Act (FFATA or Transparency Act – P.L. 109-282, as amended by section 6202(a) of P.L. 110-252),
found at https://www.fsrs.gov/. The associated Grant Reporting Certification Form and completion instructions will be
sent to the subrecipient from ADHS Program(s) responsible for the specific contract. The subrecipient or sub-awardee
must return the completed form to ADHS Program(s) by the 15th of the month following that in which the award was
received. Failure to complete a required Grant Reporting Certification Form may result in loss of funding.
21.
Technology Replacement
In any event where product is discontinued, no longer available or technically inferior to newly developed product, the
Contractor shall provide an equivalent replacement model at no additional cost and shall honor the original contract
terms
22.
Authorization for Provision of Services
CONTRACT NUMBER
INTERGOVERNMENTAL AGREEMENT
TERMS AND CONDITIONS
CTR065198
Page 16 of 23
Revised 3/24/2023
Authorization for purchase of services under this Agreement shall be made only upon ADHS issuance of a Purchase
Order that is signed by an authorized agent. The Purchase Order will indicate the Agreement number and the dollar
amount of the funds authorized. The Contractor shall only be authorized to perform services up to the amount of the
Purchase Order. ADHS shall not have any legal obligation to pay for services in excess of the amount indicated on
the Purchase Order. No further obligation for payment shall exist on behalf of ADHS unless 2) the Purchase Order
is changed or modified with an official ADHS Procurement Change Order, and/or an additional Purchase Order is
issued for purchase of services under this Agreement.
Additional Terms and Conditions for Title 2, Subtitle A, Chapter II, Part 200, Subpart C: §200.201 USE OF
GRANT AGREEMENTS (INCLUDING FIXED AMOUNT AWARDS), COOPERATIVE AGREEMENTS AND
CONTRACT
23.
Civil Rights Assurance Statement. The Contractor and Subcontractors are subject to Title VI of the Civil Rights
Act of 1964, Section 504 of Rehabilitation Act of 1973, Title II of the Americans with Disabilities Act of 1990, the Age
Discrimination Act of 1975, Title IX of the Education Amendment of 1972, and offers all persons the opportunity to
participate in programs or activities regardless or race, color, national origin, age, sex, or disability. Further, it is agreed
that no individual will be turned away from or otherwise denied access to or benefit from any program or activity that
is directly associated with a program of the RECIPIENT on the basis of race, color, national origin, age, sex (in
educational activities) or disability.
24.
Americans With Disabilities Act of 1990.
24.1.
The Contractor shall comply with the Americans With Disabilities Act of 1990 (Public Law 101-336) and the
Arizona Disability Act of 1992 (A.R.S § 41-1492 et. seq.), which prohibits discrimination of the basis of
physical or mental disabilities in delivering contract services or in the employment, or advancement in
employment of qualified individuals.
24.2.
Persons with a disability may request a reasonable accommodation, such as a sign language interpreter, by
contracting the Contract Manager for the solicitation. Request should be made as early as possible to allow
time to arrange the accommodation.
25.
Federal Funding. Funding for these services is contingent upon the availability of federal government funding. No
commitment of any kind is made by the State concerning this Grant unless there are monies provided by a federal
grant. The Grantee should take this fact into consideration.
25.1
For the purposes of this Grant, a capital expenditure means expenditures to acquire capital assets, as
defined in 2 C.F.R. 200.12, or expenditures to make additions, improvements, modifications, replacements,
rearrangements, reinstallations, renovations, or alterations to capital assets that materially increase their
value or useful life, with a cost of $250 or greater.
25.2
Grantee agrees to maintain property records for equipment purchased with grant funds and perform a
physical inventory and reconciliation with property records at least every year. Grantee agrees that funds
will not be used for the construction of new facilities.
25.3
Grantee agrees to follow equipment disposition policies as determined by the Federal Awarding Agency at
Award Completion or as depicted in the State of Arizona Accounting Manual. Grantee also agrees to follow
the directives in ADHS Property and Procedure Policy FIN 111.
25.4
Charges to Federal awards for salaries and wages must be based on records that accurately reflect the
work performed. These records must: Be supported by a system of internal control which provides
reasonable assurance that the charges are accurate, allowable, and properly allocated; Be incorporated
into the official records of the non-Federal entity; Reasonably reflect the total activity for which the employee
is compensated by the non-Federal entity, not exceeding 100% of compensated activities (for IHE, this per
the IHE's definition of IBS); Encompass both federally assisted and all other activities compensated by the
non-Federal entity on an integrated basis, but may include the use of subsidiary records as defined in the
non-Federal entity's written policy; Comply with the established accounting policies and practices of the
CONTRACT NUMBER
INTERGOVERNMENTAL AGREEMENT
TERMS AND CONDITIONS
CTR065198
Page 17 of 23
Revised 3/24/2023
non-Federal entity (See paragraph above for treatment of incidental work for IHEs.; and Support the
distribution of the employee's salary or wages among specific activities or cost objectives if the employee
works on more than one Federal award; a Federal award and non-Federal award; an indirect cost activity
and a direct cost activity; two (2) or more indirect activities which are allocated using different allocation
bases; or an unallowable activity and a direct or indirect cost activity.
Budget estimates (i.e., estimates
determined before the services are performed) alone do not qualify as support for charges to Federal
awards, but may be used for interim accounting purposes only.
25.5
Grantee understands that financial reports are required as an accounting of expenditures for either
reimbursement or ADHS-approved advance payments.
25.6
The final request for reimbursement of grant funds must be received by the ADHS no later than sixty (60)
days after the last day of the award period.
25.7
All goods and services must be received or have reasonable expectations thereof and placed in service by
Grantee by the expiration of this award.
25.8
Grantee agrees that all encumbered funds must be expended and that goods and services must be paid
by GRANTEE within sixty (60) days of the expiration of this award unless funding guidelines permit funds
to be used at a future date.
25.9
Grantee agrees to remit all unexpended grant funds to the ADHS within thirty (30) days of written request
from the ADHS.
25.10
Grantee agrees to account for interest earned on federal grant funds and shall manage interest income in
accordance with the Cash Management Improvement Act of 1990 and as indicated in the State of Arizona
Accounting Manual (SAAM) located at the following website. https://gao.az.gov/publications/saam Interest
earned in excess of allowable limits must be remitted to the ADHS within thirty (30) days after receipt of a
written request from the ADHS.
25.11
Grantee agrees not to use grant funds for food and/or beverage unless explicitly approved in writing by the
ADHS.
25.12
Grantee agrees to comply with all applicable laws, regulations, policies and guidance (including specific
cost limits, prior approvals and reporting requirements, where applicable) governing the use of grant funds
for expenses related to conferences, meetings, trainings, and other events, including the provision of food
and/or beverages at such events, and costs of attendance at such events unless explicitly approved in
writing by the ADHS.
25.13
No funds shall be used to supplant federal, state, county or local funds that would otherwise be made
available for such purposes. Supplanting means the deliberate reduction of state or local funds because
of the existence of any grant funds.
25.14
Grantee agrees that grant funds are not to be expended for any indirect costs that may be incurred by
Grantee for administering these funds unless explicitly approved in writing by the ADHS. This may include,
but is not limited to, costs for services such as accounting, payroll, data processing, purchasing, personnel,
and building use which may have been incurred by the Grantee.
25.15
Grantee will comply with the audit requirements of OMB Office of Management and Budget’s (OMB)
Uniform Administrative Requirements, Cost Principles and Audit Requirement for Federal Awards and
provide the ADHS with the Single Audit Report and any findings within ninety (90) days of receipt of such
finding(s). If the report contains no findings, the Grantee must provide notification that the audit was
completed. All completed Single Audits should be uploaded in the format specified to the Federal Audit
Clearinghouse no later than nine (9) months after the entities fiscal year-end at the attached Link:
https://harvester.census.gov/facweb/default.aspx/
CONTRACT NUMBER
INTERGOVERNMENTAL AGREEMENT
TERMS AND CONDITIONS
CTR065198
Page 18 of 23
Revised 3/24/2023
25.16
Grantee understands and agrees that misuse of award funds may result in a range of penalties, including
suspension of current and future funds, suspension or debarment from federal grants, recoupment of
monies provided under an award, and civil and/or criminal penalties.
25.17
Grantee agrees not to do business with any individual, agency, company or corporation listed in the
Excluded Parties Listing Service.
Link: System for Award Management https://www.sam.gov/portal/public/SAM/
25.18
Grantee agrees to ensure that, no later than the due date of the Grantee’s first financial report after the
award is made, Grantee and any subgrantees have a valid UEI profile and active registration with the
System for Award Management (SAM) database.
25.19
GRANTEE certifies that it presently has no financial interest and shall not acquire any financial interest,
direct or indirect, which would conflict in any manner or degree with the performance of services required
under this Agreement.
25.20
Compliance with 41 U.S.C. 4712 (including prohibitions on reprisal; notice to employees) Grantee must
comply with, and is subject to, all applicable provisions of 41 U.S.C. 4712, including all applicable
provisions that prohibit, under specified circumstances, discrimination against an employee as reprisal
for the employee's disclosure of information related to gross mismanagement of a federal grant, a gross
waste of federal funds, an abuse of authority relating to a federal grant, a substantial and specific
danger to public health or safety, or a violation of law, rule, or regulation related to a federal grant.
25.21
GRANTEE certifies to comply with the Drug-Free Workplace Act of 1988, and implemented in 28 CFR Part
83, Subpart F, for grantees, as defined in 28 CFR, Part 83 Sections 83.620 and 83.650.
26.
Comments Welcome
The ADHS Procurement Office periodically reviews the Uniform Terms and Conditions and welcomes any comments
you may have. Please submit your comments to: ADHS Procurement Administrator, Arizona Department of Health
Services, 150 North 18th Avenue, Suite 280, Phoenix, Arizona 85007.
CONTRACT NUMBER
INTERGOVERNMENTAL AGREEMENT
SCOPE OF WORK
CTR065198
Page 19 of 23
Revised 3/24/2023
1.
Background
1.1. The mission of the Arizona Department of Health Services (ADHS) Office of HIV & Hepatitis C Services is to
conduct Human Immunodeficiency Virus (HIV) and hepatitis C surveillance activities and provide services to
prevent and treat HIV and hepatitis C in Arizona;
1.2. The ADHS Office of HIV & Hepatitis C Services has the responsibility of administering:
1.2.1.
HIV Prevention Cooperative Agreement Funds,
1.2.2.
HIV Surveillance Program Cooperative Agreement funds,
1.2.3.
Ryan White HIV/AIDS Treatment Extension Act of 2009 administered by the Health Resources
Services Administration (HRSA), HIV/AIDS Bureau (HAB) Ryan White funding, and
1.2.4.
Hepatitis C Cooperative Agreement Funds.
1.3. The strategies proposed herein embody discrete areas of activity, which, based on the best available scientific
evidence and experience, Centers for Disease Control and Prevention (CDC) believes will most rapidly
accelerate efforts to reduce new HIV infections and merit undertaking. Funding for this Contract is provided
by CDC-RFA-PS20-2010 Integrated HIV Programs for Health Departments to Support Ending the HIV
Epidemic Component C. The “Ending the HIV Epidemic” (EHE) initiative is intended to build on the on-going
activities funded through PS18-1802: Integrated HIV Surveillance and Prevention Programs for Health
Departments to strategically advance (i.e., initiate new or expand existing) HIV prevention efforts;
1.4. The current National HIV/AIDS strategy has four (4) goals:
https://www.aids.gov/federal-resources/national-hiv-aids-strategy/nhas-update.pdf
1.4.1.
Reducing New HIV Infections,
1.4.2.
Increasing Access to Care and Improving Health Outcome for People Living with HIV,
1.4.3.
Reducing HIV-related Disparities and Health Inequities, and
1.4.4.
Achieve integrated, coordinated efforts that address the HIV epidemic among all partners and
stakeholders.
1.5. Services funded under this contract focus on Pre-Exposure Prophylaxis for HIV Prevention (PrEP) and non-
occupational Post Exposure Prophylaxis for HIV prevention (nPEP) Navigation Services and Linkage to Care.
2.
Objective
2.1. Increased awareness of PrEP and nPEP for persons receiving Sexually Transmitted Infection (STI) and HIV
testing at the Maricopa County Department of Public Health (MCDPH) Sexually Transmitted Disease (STD)
Clinic;
2.2. Linkage to PrEP navigation services for persons for whom PrEP services is indicated;
2.3. Provision of PrEP navigation services through the MCDPH STD Clinic;
2.4. Linkage of PrEP eligible patients to community-based clinics prescribing PrEP in Maricopa County; and
2.5. Increase uptake of PrEP utilization among persons at risk for HIV in Maricopa County.
3.
Scope of Service
3.1. MCDPH STD clinic will provide PrEP navigation services and linkage to care for persons at risk of acquiring
HIV in Maricopa County;
CONTRACT NUMBER
INTERGOVERNMENTAL AGREEMENT
SCOPE OF WORK
CTR065198
Page 20 of 23
Revised 3/24/2023
3.2. Any persons at risk for acquiring HIV are eligible participants in the PrEP Navigation program;
3.3. Coordinate with community partners in Maricopa County to develop a county wide system of care for PrEP
services for persons at risk for HIV;
3.4. Implement Rapid Start linkage of patients eligible for PrEP to a medical provider that can prescribe PrEP in
Maricopa County;
3.5. Provide culturally competent services, as defined by compliance with the CLAS (Culturally and Linguistically
Appropriate Services):
3.5.1.
Implement organizational policies that comply with the CLAS standards, and
3.5.2.
Develop a plan, to be approved by ADHS, for enhancement of cultural competency, delivery of
services and staff training.
4.
Tasks
4.1. Rapid Start for HIV Negative Persons / PrEP Navigation:
4.1.1.
Provide PrEP information to every patient that has an HIV test in the STD clinic. Patient shall be offered
PrEP and PEP educational information as well as Patient Navigator contact information,
4.1.2.
Place PrEP and PEP promotional posters for the clinic exam rooms and the clinic waiting room,
4.1.3.
Patients shall be offered same day or next day PrEP navigation appointments. Early morning or late
evening appointments shall be offered starting at seven (7:00) am and ending at six (6:00) pm,
4.1.4.
Utilize the patient portal, text messaging and email messaging to patients who have received an HIV test
to notify them that PrEP navigation services are available and how to get assistance,
4.1.5.
Patient Navigators shall utilize the Rapid Start network of community partner clinics to refer patients to
PrEP prescribers so they can rapidly initiate medical care,
4.1.6.
Patient navigators shall link patients wanting to access PrEP care to a medical provider in the community
within five (5) calendar days on average,
4.1.7.
Patient Navigators shall follow up with all PrEP referrals to community partner clinics after the scheduled
appointment, at thirty (30) days, and at three (3) months, to confirm completion of appointment and
retention in PrEP care. The exception shall be patients referred to and navigated by HIV Prevention
funded community partner organizations for ongoing PrEP navigation. HIV Prevention funded community
partner organizations doing ongoing navigation shall be responsible for ongoing follow up,
4.1.8.
Patient navigators shall help patients navigate their insurance coverage, assess health insurance
coverage and assist patients in enrolling in AHCCCS/Medicaid and Patient Assistance Programs to help
remove financial barriers to PrEP access,
4.1.9.
Patient navigators shall assess barriers to PrEP access such as food insecurity, housing insecurity,
employment, and transportation and work with patient to assist them in overcoming these barriers,
4.1.10. Patient navigators shall maintain records based on patient self-report of patients who received a PrEP
prescription at a community partner clinic,
4.1.11. Complete reporting for patients receiving PrEP services as required by CDC, and
4.1.12. Participate in monthly cooperative agreement calls with CDC and any other calls, monitoring, meetings,
and site visits as required by the CDC for the project:
CONTRACT NUMBER
INTERGOVERNMENTAL AGREEMENT
SCOPE OF WORK
CTR065198
Page 21 of 23
Revised 3/24/2023
4.1.12.1. There will be twelve (12) monthly meetings annually that require Contractor attendance;
4.1.12.2. CDC Component C Meeting – attend up to one (1) out of state CDC Component C meeting
annually if scheduled by CDC; and
4.1.12.3. Participate in up to one (1) on site CDC subrecipient site visit annually.
5.
Deliverables and Delivery Schedule
5.1. Contactor’s Expenditure and Activity Report is thirty (30) days after month or quarter identified in Claim for
services rendered;
5.2. Provide annual updated detailed budget and work plan for CDC by May 1st on an annual basis;
5.3. By the 7th of each month, provide strategy updates on clinic infrastructure, scaling up evidence-based
approaches, PrEP and nPEP clinic and lab capacity HIV medical care, and partnerships to CDC in written
reports and monthly cooperative agreement. This takes place at the monthly meeting with the CDC
Component C project officer and staff; and
5.4. Report every six (6) months to ADHS on data required by the CDC for project activities. Detailed data
reporting requirements are provided in Attachment One (1): STD Clinic Capacity & Patient Outcomes
Aggregate Reporting Guidance. The six-month (6) data report will be due to ADHS thirty (30) days after the
end of the six-month (6) reporting period. The two (2) six (6) month reporting periods in the year are January
to June and July to December.
6.
Notices, Correspondence, and Reports
6.1. Notices, correspondence, reports and invoices/CERs from the contractor to ADHS shall be sent to:
Eduardo E. Moreira
HIV Prevention Manager
Office of HIV & Hepatitis C Services
Arizona Department of Health Services
150 North 18th Avenue, Suite 280, Phoenix, AZ 85007
Email; eduardo.moreira-orantes@azdhs.gov
Phone: 480-698-5233
6.2. Notices, correspondence, and reports (and payments if sent to same address) from ADHS to the contractor shall
be sent to:
Issmene Delgado
Finance Business Analyst
Clinical Services
Maricopa County Department of Public Health
1645 E Roosevelt St Phoenix, AZ 85006
Email: Issmene.Delgado@maricopa.gov
Phone: 602-372-1485
CONTRACT NUMBER
INTERGOVERNMENTAL AGREEMENT
PRICE SHEET
CTR065198
Page 22 of 23
Revised 3/24/2023
Annual PrEP Navigation Services Component C Budget
Budget Line Item
Amount
Personnel*
$401,334
Employee Related Expenses*
$174,968
Professional & Outside Services
$0
Travel*
$10,000
Other Operating Expenses*
$101,850
Equipment*
$7,500
Indirect (15%)
$104,348
Total Annual Not To Exceed Amount:
$800,000
*Indicates indirect rate calculation
CONTRACT NUMBER
INTERGOVERNMENTAL AGREEMENT
ATTACHMENT ONE (1)
CTR065198
Page 23 of 23
Revised 3/24/2023
Contents
A. Context & Background ............................................................................................................... 1
Table 1 – Primary Performance Measures related to Patient Outcome and Clinic Capacity
Data for EHE/MHAF ..................................................................................................................... 3
B. Overarching Responsibilities/Activities of Collaborators ......................................................... 4
i. Fidelity to Data Collection Standards ....................................................................................... 4
ii. Adherence to Data Security and Confidentiality Requirements ............................................. 4
iii. NNPTC’s Roles/Responsibilities .............................................................................................. 5
iv. CDC’s Roles/Responsibilities ................................................................................................... 6
C. Uses of Aggregate Data .............................................................................................................. 6
D. Clinic-Based Patient Outcome Data Aggregation Activities ..................................................... 7
i. Population of Interest ............................................................................................................... 7
ii. Data Management ................................................................................................................... 7
Figure 1 – Sample Clinic-Level Aggregate Data Management Flow ........................................ 8
iii. Key Definitions ........................................................................................................................ 9
iv. Data Submission Schedule .................................................................................................... 10
E. Reporting Aggregate Data to CDC ............................................................................................ 10
i. Methods ................................................................................................................................. 10
ii. CDC Data Management ......................................................................................................... 10
Figure 2 – CDC Data Management Process ........................................................................... 11
Appendix 1 Data Tables, Rationale and Definitions/Clinic Capacity ........................................... 12
Appendix 1 Clinic Service Capacity Domains ............................................................................... 15
Appendix 2 Patient Outcome Measures ...................................................................................... 18
Table A: HIV Testing Domain ............................................................................................. 18
Table B: PrEP Domain ........................................................................................................ 20
Table C: STD Testing Domain ............................................................................................ 23
Appendix 3 CDC Data Dictionary .................................................................................................. 25
Version 8
A. Context & Background
This document provides guidance to STD Clinics and to the National Network of Prevention Training
Centers (NNPTCs) for clinic capacity and aggregate patient outcome reporting by STD Clinics in
support of Component C of the Integrated HIV Programs for Health Departments to Support Ending
the HIV Epidemic in the United States (EHE, CDC-RFA-PS20-2010) and subcomponent B1 of the
National Network of Sexually Transmitted Diseases Clinical Prevention Training Centers (NNPTC, CDC-
RFA-PS20-2004).
The purpose of collecting data outlined in this document is to monitor delivery of HIV related services
in the selected STD clinics, assess changes in clinic capacity over time, direct appropriate and targeted
technical assistance to recipients, help identify priorities for expansion or change in services, and to
complement other information about this work (such as cooperative agreement-related progress
reports and workplans).
The data from the clinic capacity measures will be used to generate reports that characterize clinics’
progress, in the aggregate as well as by individual clinic. Findings will be disseminated to various
audiences such as STD clinics, prevention training centers, CDC staff directly supporting this work, and
other partners outside of the DSTDP such as DHP and OIDP. The clinic capacity measures are a subset
of the Recommendations for Providing Quality Sexually Transmitted Diseases Clinical Services, 2020
(aka “QCS Tool”). For more information about the QCS Tool, including the full version of the tool and
the associated MMWR, please visit https://www.cdc.gov/std/qcs/default.htm.
Protocols for aggregate patient outcome data reporting by STD clinics, in support of Component C of
the Integrated HIV Programs for Health Departments to Support Ending the HIV Epidemic in the
United States (EHE, CDC-RFA-PS20-2010) and subcomponent A1 of the National Network of Sexually
Transmitted Diseases Clinical Prevention Training Centers (NNPTC, MHAF-funded, CDC-RFA-PS20-
2004 A1) are intended to guide reporting of patient outcome measures relevant to those initiatives.
The goal of aggregate patient outcome reporting is to monitor patient outcomes resulting of
programmatic activities at the clinic level to enhance, promote and increase the number of patients
that receive HIV-related services in STD clinics. The measures focus on a select number of high
priority outcomes: individuals tested for HIV and new diagnoses, patients assessed for eligibility for
HIV pre-exposure prophylaxis (PrEP) and PrEP provision, and patients assessed for HIV infection risk
associated with rectal bacterial infections. The overall data collection concept comprises select,
aggregate patient-level outcomes, as described in this document, reported routinely by collaborating
STD clinics to CDC through consensus protocols and standardized reporting mechanisms.
The Division of STD Prevention (DSTDP) is actively collaborating with colleagues in the Division of HIV
Prevention (DHP) to assure harmonization of aggregate data elements and definitions across other
aggregate performance measures required of recipients of CDC-RFA-PS20-2010. By design, most of
2
Version 8
these patient-level aggregate measures mirror reporting required of PS20-2010 Component A
recipients.
Table 1 lists high-level clinic capacity measures and patient outcome performance measures for
DSTDP’s work, provides detailed domains of measurement and shows which of those are also
requested under EHE/Component A (marked with an asterisk). This document outlines the overall
protocol for reporting clinic capacity and patient outcomes measures. Component A of CDC-RFA-
PS20-2010 includes numerous other measures not represented here, specific to that component.
Also, for each measure, there are additional context measures requested, so the total data collection
effort is larger than that represented in the tables below. Appendix A presents the more detailed
data tables that will be used to report on these measures. This appendix also outlines data requested
of Component C clinics versus those that are not receiving funding through Component C but
collaborating with NNPTCs through CDC-RFA-PS20-2004.
3
Version 8
Table 1 – Primary Performance Measures related to Patient Outcome and Clinic Capacity Data for
EHE/MHAF
DSTDP’s primary performance measures for its funded EHE and MHAF work
C = EHE Component C clinics Non-C = Clinics not receiving funding through Component C
Type of
Measure
Number
Associated Strategy
Measure
Patient
outcome:
C & non-C
PM-1*
Conduct routine HIV testing in
health care settings
1A1.1A Percentage of persons tested in
health care facilities identified as a priority
for routine opt-out HIV screening
Patient
outcome:
C only
PM-2*
Conduct routine HIV testing in
health care settings
1A1.1B Percentage of persons who
received an HIV-positive test result in a
health care facility that was identified as a
priority for routine opt-out HIV screening
Patient
outcome:
C and non-C
PM-3*
Conduct routine HIV testing in
health care settings
1A1.1C Percentage of persons newly
diagnosed with HIV in a health care facility
that was identified as a priority for routine
opt-out HIV screening
Patient
outcome:
C only
PM-14*
Deliver PrEP services in health
care settings
3A1.1 Percentage of persons testing
negative for HIV who are screened for
PrEP
Patient
outcome:
C only
PM-15*
Deliver PrEP services in health
care settings
1A4.1 and 1B4.2 Percentage of persons
who are screened and eligible for PrEP
referral
Patient
outcome:
C and non-C
PM-16*
Deliver PrEP services in health
care settings
1A4.2 and 1B4.3 Percentage of persons
eligible and referred to a PrEP provider
Patient
outcome:
C only
PM-17*
Deliver PrEP services in health
care settings
3A1.3 Percentage of persons eligible
and linked to a PrEP provider
STD specific measures
Patient
outcome:
C and non-C
PM-STD-1
Conduct extragenital screening
for STDs
Percent of persons tested for rectal GC/CT
who are positive for rectal GC/CT
Patient
outcome:
C and non-C
PM-STD-2
Provide PrEP at the STD clinic
Percent of persons eligible for PrEP who
receive PrEP at the STD clinic
Clinic capacity:
C and non-C
PM-STD-3
Strengthen STD clinic capacity to
provide HIV prevention, care, and
treatment services
Number of HIV prevention and referral
services provided routinely by STD clinics
Clinic capacity:
C and non-C
PM-STD-4
Strengthen STD clinic capacity to
provide HIV prevention, care, and
treatment services
Number of HIV laboratory services offered
routinely by STD clinics
Clinic capacity:
C and non-C
PM-STD-5
Strengthen STD clinic capacity to
provide HIV prevention, care, and
treatment services
Number of HIV treatment services offered
routinely by STD clinics
Clinic capacity:
C and non-C
PM-STD-6
Strengthen STD clinic capacity to
provide HIV prevention, care, and
treatment services
Number of service models offered
routinely STD clinics
4
Version 8
B.
Overarching Responsibilities/Activities of Collaborators
As part of a guidelines-based monitoring and evaluation effort, collaborating partners will maintain
compliance with agreed-upon data reporting and data management standards, agree to consensus
schedules for clinic capacity and aggregate patient outcome data reporting and commit to ongoing
data quality assurance.
i.
Fidelity to data collection
Patient outcome monitoring is an aggregate data reporting activity; no individual, patient-level records
are made available to CDC. Adherence to reporting guidance, data definitions and recommendations
for clinic-level aggregate data is important for assuring fidelity of reported data while maintaining
comparability across all clinics contributing data.
CDC and NNPTC staff will work with collaborating clinics to provide for reasonable local flexibility in
implementing specific activities, where necessary, to reflect local public health, clinical contexts and
conditions. NNPTC partners will also work with collaborators and CDC to identify and address relevant
training and/or technical assistance needs to assure success of EHE/MHAF aggregate data collection
activities.
ii.
Adherence to data security and confidentiality requirements
Collaborating clinics may or may not be affiliated with public health departments, and from this
perspective are considered covered entities under HIPAA regulation. However:
“Without individual authorization, a covered entity may disclose protected health information to a public
health authority that is legally authorized to collect or receive the information for the purposes of
preventing or controlling disease, injury, disability including, but not limited to reporting of disease...and
conducting public health surveillance…” (MMWR, 2003).
EHE/MHAF initiatives value the principles embodied in these protections and strives to establish and
maintain the highest level of performance in protecting the confidentiality and security of all
information. Aggregate data reported to CDC must not contain personal identifiers such as name, social
security number, date-of-birth, street address, or medical record number.
Unique, personally identified clinic visit, patient and laboratory information are critical for the success
of these reporting activities at the clinic level and should be extracted into clinic-maintained databases
or a set of related tables from which aggregate reporting is exported. To do this reliably, the unique
5
Version 8
identifiers associated with individual patients and related health events must be maintained over the
full EHE/MHAF project periods.
To protect the confidentiality of all locally maintained data, collaborating clinics agree to abide by the
principles embodied by the “Data Security and Confidentiality Guidelines for HIV, Viral Hepatitis,
Sexually Transmitted Disease, and Tuberculosis Programs: Standards to Facilitate Sharing and Use of
Surveillance Data for Public Health Action”, available here:
http://www.cdc.gov/nchhstp/programintegration/docs/PCSIDataSecurityGuidelines.pdf
All aggregate data reported to CDC by collaborating clinics must be transported using encrypted, secure
transport methods approved by CDC (SAMS). Data stored at CDC will be maintained on secure servers
with multi-layered access restrictions and accessible to staff on an “as needed” basis.
iii. NNPTC Roles/Responsibilities
The National Network of Sexually Transmitted Disease Clinical Prevention Training Centers (NNPTC) is
collaborating in this initiative under Subcomponent A1, scaling up regional HIV prevention services in
STD specialty clinics, of CDC-RFA-PS20-2004. This subcomponent funds NNPTC partners to assess the
provision of HIV preventive services in STD specialty clinics to identify gaps and needs, develop
training and technical assistance in HIV preventive services, and to establish and nurture learning
communities for STD specialty clinic providers with respect to vital HIV preventive services such as
pre-exposure prophylaxis, post-exposure prophylaxis and in scaling up HIV testing to identify new or
currently untreated HIV infection.
Under this scope of work, NNPTC partners will work closely with selected regional STD specialty clinics
to assure promotion, uptake, and enhancement of HIV preventive services. NNPTC partners are thus
also key collaborating partners in data collection, reporting and use of the information to drive critical
training and technical assistance (TA) on HIV preventive interventions. As TA and capacity
building providers, the NNPTCs will help collaborating STD clinics use their own local data for
program improvement and report aggregate data to CDC as outlined here. The nature and
extent of that assistance will vary by PTC and clinic, depending on capacity and needs.
In their capacity as a Coordinating Center for the A1 work, Denver Health will facilitate discussion and
communication related to these requirements among PTCs and with CDC. Denver Health and CDC
will collaborate around reporting these and other data related to this work back to PTCs
and to collaborating STD clinics, as appropriate.
6
Version 8
iv. CDC Roles / Responsibilities
Substantial involvement by CDC collaborators includes:
• Coordination and dissemination of reporting, monitoring and evaluation protocols
• Facilitation of routine communications
• Coordination of conference calls and meeting(s)
• Provision of infrastructure for secure transport of aggregate reports to CDC
• Provision of technical assistance and training (limited, targeted)
• Monitoring of progress and reporting to relevant stakeholders
• Management of data warehouse or other CDC central data stores to support aggregate
reporting
• Summary and aggregate reporting to CDC leadership, clinic collaborators and external
stakeholders
C.
Uses of Aggregate Data
Aggregate data collection and reporting as described in this protocol will be used to:
• Provide invaluable information to monitor delivery of HIV preventive services in the selected
STD specialty clinics
• Longitudinally assess changes in patient-level services and
• Provide information useful for clinical quality improvement
These data will be used to describe the extent and growth of these patient services among these
clinics and over time. CDC will aggregate information where appropriate, to describe the total “reach”
among clinics and compare clinics to one another. CDC will produce:
1) Reports for each PTC, to share back with their clinics as part of their ongoing discussions about
program improvement and milestones
2) National reports, to share with PTCs and clinics as well as with its stakeholders like DHP and
others who need to know progress on this work
3) Reports based on these data will describe results overall and by clinic, and they will be tailored
for various audiences: collaborating STD clinics, PTCs, CDC staff directly supporting this work,
and other stakeholders outside of DSTDP such as DHP and HHS/Office of the Infectious Disease
Policy (OIDP) which manages the Minority HIV/AIDS Fund (MHAF)
This information will complement other information about this work, related to changes in clinic
capacity, technical assistance provided, and program implementation as described in work plans and
progress reports. These patient outcome measures will tell an important part of the story about the
extent to which collaborating STD clinics contribute to HIV outcomes.
7
Version 8
Given clinics'
baseline
service status
What do they
focus on for
strengthening/
expansion?
What TA do
they receive to
meet those
goals?
Does clinic
capacity
change?
Do patient
outcomes
change?
What facilitates
and hinders all
of this?
CDC will be tracking, collectively and for each clinic, region and NNPTC catchment area the following:
D.
Clinic-Based Patient Outcome Data Aggregation Activities
Collaborating STD clinics are expected to have (or to develop) capacity to extract record-level data
from existing clinic health record systems for aggregating patient visits, laboratory data,
demographics, and behavioral data, including by gender of sex partners. Clinics are expected to
develop their own local processes to manipulate, map and re-code data from EHR/EMR into new
variables for aggregate reporting every six months. Clinics will be responsible for creating tables,
maintaining an archive of required datasets for reporting using locally available resources (Excel, SAS,
Access, SPSS, SQL, etc.) and can run simple pivots/frequencies needed to produce data needed for
aggregate reporting using Excel tables to CDC.
i.
Population of Interest
The population of interest includes the domain of all clinics for clinic capacity measures, and all
patients presenting for care and/or STD preventive services in participating STD clinics for aggregate
patient outcome reporting.
ii.
Data Management
Data abstraction is to be performed at the individual clinic level and should include all relevant
information needed to accomplish aggregate reporting (additional detail on specific metrics is
available in appendices) and will likely entail the ability to maintain the following data abstracted
from the clinic’s EMR as a report or in separate databases or excel workbooks, depending on local
capacity:
• Clinic Visit Records: Visit-level records with unique patient IDs and data elements pertaining
to services received during the clinical encounter.
• Unique Patients: table/dataset with one record per unique patient that includes intrinsic
patient characteristics such as age, sex at birth, current sex, Hispanic ethnicity, race, MSM
indicator, etc. This table should serve as the source for aggregate reporting and will be
supplemented with information distilled across potentially multiple clinic visits. Such data will
include HIV status (self-report and/or testing confirmed as of the earliest record in the report
period), rectal GC/CT testing, rectal GC/CT results, HIV testing during the report period, PrEP
assessments, PrEP eligibility, PrEP referral, PrEP linkage and PrEP prescription.
8
Version 8
• Laboratory Records: Clinics may also choose to create a separate dataset of laboratory data
related to CT/GC and HIV testing if these data are not available in their EMR associated with
the unique patient visit. This data set should include a unique patient ID for merging with
patient tables.
Each STD clinic will likely have different electronic health records and have data systems that have
been developed and modified over time to fit their particular clinical practice environment. No single
solution will fit the data management requirements across all reporting STD clinics. But a few general
principles may be useful to consider in aggregating patient data for reporting outcomes for PS20-
2010 and for PS20-2004.
Consider the aggregate data metrics in several buckets. 1) The overall patient census will come from
visit-level records in the clinics EHR. The primary source for reporting is a list of the unique persons
that visited the clinic at least once during the report period. Some patients will have multiple visits
and you will need to use the patient ID (medical record number, client ID, patient ID, etc.) to develop
a list/panel with a single row for each individual patient with their demographics (age, race, gender
ID); 2) Risk or population information, as well as HIV-status and PrEP referral/utilization may come
from the visits over time or may be recorded in the most recent visit. Some of these data may also
come from separate record-keeping systems (e.g., separate PrEP data), and you would use the
patient ID or name to merge into a single record for each patient. 3) Testing and screening data may
come from a separate laboratory database or may be merged into the patient’s visit record – these
data will allow you to determine if the patient was tested for HIV at one or more clinic visits. This
high-level scheme is diagrammed in Figure 1.
Figure 1: Example of Possible Clinic-Level Patient Outcome Aggregation
(for EMR/EHR)
9
Version 8
iii.
Key Definitions
Clinics should consider the following broad guidelines for category definitions in reporting their
patient outcome measures. In recognition of existing variability in electronic health data systems and
the longstanding use of locally defined patient information needed for clinical management of
patients seeking care in sexual health settings, flexibility in some definitions is warranted, particularly
with respect to population-level HIV risk characteristics.
Population Group: This stratification in reporting tables A – C asks reporting clinics to provide the
aggregate counts of patients provided HIV services in mutually exclusive categories indicating HIV
transmission/acquisition risk. Many different look-back windows for HIV risk behaviors have been
used in past data collection projects at the national and local level, and for sexual health providers
look-back windows for risk are often determined based on the bacterial or viral STI of interest,
ranging from 60-days, 90-days, 6-months to 12 months. While a broader definition of a 5-year look-
back period has been proposed for aggregate reporting for PS20-2010 Component C, the cost and
potential disruption of modifying existing clinic flow and clinician practice in sexual health services
settings argues compellingly for latitude and flexibility in look-back timeframe definitions. As the goal
of this aggregate data collection is to measure increases in direct HIV-related diagnostic and high-
impact preventive services provided to patients, rather than to surveil the proportion of patients in
specific risk categories, local definitions may be used for reporting patients in these strata.
o MSM/IDU – cisgender men reporting sexual contact with other cisgender men AND reporting
injection drug use within the locally-defined look-back period.
o MSM (Only) – cisgender men reporting sexual contact with other cisgender men with no
evidence of injection drug use within the locally-defined look-back period.
o PWID (Only) – cis and or transgender men or women reporting injection drug use within the
locally-defined look-back period with no concurrent MSM risk.
o Heterosexual Cisgender Males – cisgender men reporting sexual contact with cisgender
women only AND no evidence of injection drug use within the locally-defined look-back period
o Heterosexual Cisgender Females – cisgender women reporting sexual contact with cisgender
men only AND no evidence of injection drug use within the locally-defined look-back period.
o Other – Patients with documented absence of above listed risks within the locally-defined
look-back period and documented report of any other HIV exposure risks (occupational,
perinatal exposure, etc.).
o Unknown – Patients for whom all risk information is missing and/or refusing to provide any
HIV risk information.
Reporting clinics should describe their specific local look-back timeframes in the QA memo
accompanying their aggregate data report (see below).
10
iv.
Data Submission Schedule for Clinic Capacity and Patient
Outcome Measures
Data submission guidance is harmonized with the schedule adopted by DHP's EHE Component A. The
data submission process may differ between EHE Component C and non-C clinics collaborating with
NNPTCs, given the cycles of the two cooperative agreements are different. However, CDC will strive
to align these wherever possible.
Reporting Period Records Start Date
Reporting Period Records End Date
Report Due to CDC
(1)
01 Jan 2021
30 Jun 2021
15 Sept 2021
(2)
01 Jul 2021
31 Dec 2021
15 Mar 2022
(3)
01 Jan 2022
30 Jun 2022
15 Sept 2022
(4)
01 Jul 2022
31 Dec 2022
15 Mar 2023
(5)
01 Jan 2023
30 Jun 2023
15 Sept 2023
(6)
01 Jul 2023
31 Dec 2023
15 Mar 2024
E.
Reporting Aggregate Data to CDC
i. Methods
Collaborating STD Clinics will submit Excel spreadsheets with the required information directly to CDC
(or to their NNPTC lead agency for CDC-RFA-PS20-2004) through secure data transmission processes
(to be described in more detail later). There should be two Excel workbooks per clinic for each report
period—one for the patient outcomes data and one for their clinic capacity assessment. NNPTCs will
be expected to submit individual Excel files for each of the non-C clinics they are working with to CDC
on the same data transmission schedule.
Clinics should also prepare a separate ‘memo’ that they will submit via e-mail to CDC or to their
regional NNPTC that describes any caveats on the reported data or explains any missing data. A
template for this QA Memo will be distributed in the month prior to each data submission date.
ii. CDC Data Management
Upon receipt of the files, CDC will individually check for completeness and obvious errors or
omissions, with rapid follow up to the sender if needed based on information in the QA Memo that
accompanies the data. Files received from clinics will be stored in a secure share drive at CDC with
limited access only for staff working on this initiative. Using standard data management techniques,
the clinic-level information will be merged into a single data file, resulting in a dataset including all
clinics’ data for a particular reporting period. This dataset will be further checked and reviewed prior
to analysis, to identify any issues that require follow-up with recipients.
Version 8
11
Version 8
Figure 2: CDC Process Flow for Aggregate Data
12
Version 8
Appendix 1: Data tables, Rationale and Definitions – Clinic
Capacity Measures
Primary Performance Measures for STD Clinic Capacity for EHE/MHAF
(1) Prevention and Referral Measures
Rationale
# of prevention and referral services
offered routinely by STD clinics
This measure is intended to reflect HIV-related prevention
services routinely provided by STD clinics. These services are
paramount in preventing the acquisition and transmission of
HIV.
Data Field
Notes/Tips
Risk assessment and education for
pre-exposure prophylaxis (PrEP) for
HIV Prevention
This includes providing education and information about PrEP
to patients; various methods could be employed to do so.
Risk assessment includes use of a patient's information to
determine if they might be a good candidate for PrEP, based
on their self-reported behaviors and other information. Both
education and patient risk assessment must be provided to
warrant a "yes" in this field. Providing information alone is
insufficient to be counted here.
Referral to PrEP providers
Referral to a PrEP provider is a process involving the provision
of information on who the providers are, what documents a
referred person should take with them, providers
location/contact information, and what to expect from the
referral process.
Linkage to PrEP providers
Linkage to PrEP provider is the process through which a
person at risk for becoming infected with HIV is helped to
access a healthcare provider who offers evaluation and
management for PrEP. Linked to a PrEP provider refers to the
outcome of the referral or linkage of a PrEP eligible person to
a PrEP provider, as indicated by the person’s attendance at
the first appointment and verified through reviews of medical
records or other data systems or self-report by the client.
Linkage to a PrEP provider external to the STD clinic or internal
to the STD clinic would warrant a “yes” here.
Risk assessment and education for
non-occupational post-exposure
prophylaxis (nPEP)
This includes providing education and information about
nPEP to patients; various methods could be employed to do
so. Risk assessment includes use of a patient's information to
determine if they might be a good candidate for nPEP, based
on their self-reported behaviors and other information. Both
education and patient risk assessment must be provided to
warrant a "yes" in this field. Providing information alone is
insufficient to be counted here.
Referral or linkage to nPEP providers
Any form of referral or linkage to nPEP providers outside of
the STD clinic would warrant a "yes" here.
Referral of linkage to HIV care
Any form of referral or linkage to HIV care providers outside
of the STD clinic would warrant a "yes" here.
(2) Laboratory Capacity Measures
Rationale
# of laboratory services offered
routinely by STD clinics
Laboratory tests for identifying HIV/STDs are important for
screening and diagnostic purposes. Screening tests are the
only method for identifying asymptomatic infections. Other
laboratory tests are needed to monitor impact of treatment.
13
Version 8
This measure will provide information on the status of
laboratory services offered routinely by STD clinics over time.
Data Field
Notes/Tips
At time of patient visit: test for HIV
(rapid or laboratory)
This includes rapid tests and/or laboratory tests done at the
time of visit. Providing either is grounds to select “yes.”
Through clinical laboratory:
extragenital (pharynx and rectum)
NAAT for gonorrhea and chlamydia
Both rectal and pharyngeal testing capacity – both would be
needed to be in place to select “yes.”
Through clinical laboratory: fourth
generation antigen/antibody HIV test
HIV tests that detect HIV antibodies and p24 antigens.
Through clinical laboratory:
laboratory tests needed for providing
nPEP and PrEP, as per clinical
protocol
These would include onsite testing for all standard nPEP/PrEP
clinical evaluation and follow-up: HIV; oral, rectal, genital
GC/CT; syphilis, HBV (HbsAg); pregnancy; renal function
(creatinine and est. creatinine clearance) and liver function
(ALT/AST). All would need to be in place to select “yes.”
Viral load testing
Clinic has the capacity to test patients for HIV viral load.
(3) Treatment Measure
Rationale
# of treatment services offered
routinely by STD clinics
On-site and same-day treatment has numerous public health
benefits for preventing further transmission of HIV. This
measure will monitor, over time, the status of treatment
services by STD clinics extent to which these treatment
services by STD clinics.
Data Field
Notes/Tips
On site: provision (starter pack or 3-
month supply): PrEP
Medication given directly to patients: either PrEP starter pack
or initial course (month supply or more).
On site: provision (7-day or full
course): nPEP
Medication given directly to patients: either nPEP starter
pack (3–7 days of medication) or nPEP complete 28-day
course.
On site: treatment for acute or new
diagnosis of HIV
Medication given directly to patients: any type of ART starter
pack.
By prescription: PrEP
Prescription given directly to patients: either PrEP starter
pack or initial course (month supply or more).
By prescription: nPEP
Prescription given directly to patients: either nPEP starter
pack (3–7 days of medication) or nPEP complete 28-day
course.
By prescription: treatment for acute
or new diagnosis of HIV
Prescription given directly to patients: any type of ART
starter pack.
(4) Service Model Measures
Rationale
# of service models offered routinely
by STD clinics
Varying service models help different types of patients at
certain points along the care path, contain infection, and
reduce transmission. This measure provides information on
the extent to which these service models have been
implemented over time by clinics.
Data Field
Notes/Tips
Ongoing care for patients taking PrEP
Clinic has the capacity to serve as an ongoing source of care
and monitoring for people taking PrEP for HIV prevention.
STD express visit
The clinic provides a specific pathway for triage-based STI
testing without full clinical examination. Interaction with a
clinician may or may not occur as part of this type of visit.
14
Version 8
Telemedicine
The clinic has the capacity to provide direct clinical services to
patients by phone, video and/or use of other technology.
Provision or linkage to kits for self-
collection for GC/CT testing outside
the clinic
The clinic provides patients with kits or referrals that allow
them to manage their own STD testing outside of the clinic.
Provision or linkage to self-testing
kits for HIV testing outside the clinic
The clinic provides patients with kits or referrals that allow
them to test themselves for HIV outside of the clinic.
15
Version 8
Table A: Clinic Service Capacity Domains
ALL EHE clinics report in boxes outlined in red. (Variable names in individual cells below are for CDC
reference only; cells should be populated with clinic counts in the Excel workbooks).
16
Version 8
Table Footnotes
Notes for Prevention and Referrals
1. This includes providing education and information about PrEP to patients; various methods
could be employed to do so. Risk assessment includes use of a patient's information to
determine if they might be a good candidate for PrEP, based on their self-reported behaviors
and other information. Both education and patient risk assessment must be provided to
warrant a "yes" in this field. Providing information alone is insufficient to be counted here.
2. Referral to a PrEP provider external to the STD clinic is a process involving the provision of
information on who the providers are, what documents referred person should take with
them, how to get to the providers’ agency, and what to expect from the referral process.
3. Linkage to PrEP provider is the process through which a person at risk for becoming infected
with HIV is helped to access a healthcare provider who offers evaluation and management for
PrEP. Linked to a PrEP provider refers to the outcome of the referral or linkage of a PrEP
eligible person to a PrEP provider, as indicated by the person’s attendance at the first
appointment and verified through reviews of medical records or other data systems or self-
report by the client. Linkage to a PrEP provider external to the STD clinic or internal to the
STD clinic would warrant a “yes” here.
4. This includes providing education and information about nPEP to patients; various methods
could be employed to do so. Risk assessment includes use of a patient's information to
determine if they might be a good candidate for nPEP, based on their self-reported behaviors
and other information. Both education and patient risk assessment must be provided to
warrant a "yes" in this field. Providing information alone is insufficient to be counted here.
5. Any form of referral or linkage to nPEP providers outside of the STD clinic would warrant a
"yes" here.
6. Any form of referral or linkage to HIV care providers outside of the STD clinic would warrant a
"yes" here.
Notes for Laboratory Capacity
7. This includes rapid tests and/or laboratory tests done at the time of visit. Providing either is
grounds to select “yes".
8. Both rectal and pharyngeal testing capacity – both would be needed to be in place to select
“yes”.
9. HIV tests that detect HIV antibodies and p24 antigens.
10. These would include onsite testing for all standard nPEP/PrEP clinical evaluation and follow-
up: HIV; oral, rectal, genital GC/CT; syphilis, HBV (HbsAg); pregnancy; renal function
(creatinine and est. creatinine clearance) and liver function (ALT/AST). All would need to be in
place to select “yes.”
11. Clinic has the capacity to test patients for HIV viral load.
17
Version 8
Notes for Treatment
12. Medication given directly to patients: either PrEP starter pack or initial course (month supply
or more).
13. Medication given directly to patients: either nPEP starter pack (3–7 days of medication) or
nPEP complete 28-day course.
14. Medication given directly to patients: any type of ART starter pack.
15. Prescription given directly to patients: either PrEP starter pack or initial course (month supply
or more).
16. Prescription given directly to patients: either nPEP starter pack (3–7 days of medication) or
nPEP complete 28-day course.
17. Prescription given directly to patients: any type of ART starter pack.
Notes for Service Models
18. Clinic has the capacity to serve as an ongoing source of care and monitoring for people taking
PrEP for HIV prevention.
19. The clinic provides a specific pathway for triage-based STI testing without full clinical
examination. Interaction with a clinician may or may not occur as part of this type of visit.
20. The clinic has the capacity to provide direct clinical services to patients by phone, video
and/or use of other technology.
21. The clinic provides patients with kits or referrals that allow them to manage their own STD
testing outside of the clinic.
22. The clinic provides patients with kits or referrals that allow them to test themselves for HIV
outside of the clinic.
18
Version 8
Appendix 2: Data Tables and Definitions - Patient Outcomes
Table A: HIV Testing Domain
EHE Component C clinics report ALL columns and rows; non-Component C clinics report just
highlighted columns/rows. (Variable names in individual cells below are for CDC reference only; cells
should be population with clinic counts in the Excel workbooks)
Table A Persons Tested and Positivity in STD Clinics Conducting Routine Opt-Out HIV Testing
(A)
(B)
(C)
(D)
(E)
(F)
Total Number of
Persons Served1
Number of
Persons
Tested2,3
Number of HIV-
Positive
Persons4
Previously
Diagnosed
Persons
Newly
Diagnosed HIV-
positive
Persons5
Newly
Diagnosed HIV-
positive Persons
Identified by
Self-Report6
Age Group
N
N
N
N
N
N
<15 Years
ALT15_01
ALT15_02
ALT15_03
ALT15_04
ALT15_05
ALT15_06
15-19 Years
A1519_01
A1519_02
A1519_03
A1519_04
A1519_05
A1519_06
20-29 Years
A2029_01
A2029_02
A2029_03
A2029_04
A2029_05
A2029_06
30-65 Years
A3065_01
A3065_02
A3065_03
A3065_04
A3065_05
A3065_06
≥ 66 Years
A66_01
A66_02
A66_03
A66_04
A66_05
A66_06
Unknown
AUNK_01
AUNK_02
AUNK_03
AUNK_04
AUNK_05
AUNK_06
Gender
N
N
N
N
N
N
Cisgender Men
AM_01
AM_02
AM_03
AM_04
AM_05
AM_06
Cisgender women
AF_01
AF_02
AF_03
AF_04
AF_05
AF_06
Transgender7
ATG_01
ATG_02
ATG_03
ATG_04
ATG_05
ATG_06
Unknown
AUNKG_01
AUNKG_02
AUNKG_03
AUNKG_04
AUNKG_05
AUNKG_06
Race/Ethnicity
N
N
N
N
N
N
Hispanic or Latino Persons
AHISP_01
AHISP_02
AHISP_03
AHISP_04
AHISP_05
AHISP_06
Not Hispanic or Latino
American Indian/Alaska
Native (Alone)
AAIAN_01
AAIAN_02
AAIAN_03
AAIAN_04
AAIAN_05
AAIAN_06
Asian (Alone)
AASIAN_01
AASIAN_02
AASIAN_03
AASIAN_04
AASIAN_05
AASIAN_06
Black/African American
(Alone)
ABLACK_01
ABLACK_02
ABLACK_03
ABLACK_04
ABLACK_05
ABLACK_06
Native Hawaiian/Pacific
Islander (Alone)
ANHPI_01
ANHPI_02
ANHPI_03
ANHPI_04
ANHPI_05
ANHPI_06
White (Alone)
AWHTE_01
AWHTE_02
AWHTE_03
AWHTE_04
AWHTE_05
AWHTE_06
Multi-race
AMULT_01
AMULT_02
AMULT_03
AMULT_04
AMULT_05
AMULT_06
Unknown race/ethnicity
AUNKR_01
AUNKR_02
AUNKR_03
AUNKR_04
AUNKR_05
AUNKR_06
Population Group
N
N
N
N
N
N
MSM/IDU
AMSMID_01
AMSMID_02
AMSMID_03
AMSMID_04
AMSMID_05
AMSMID_06
MSM (Only)
AMSM_01
AMSM_02
AMSM_03
AMSM_04
AMSM_05
AMSM_06
PWID
APWID_01
APWID_02
APWID_03
APWID_04
APWID_05
APWID_06
Heterosexual males
AHETM_01
AHETM_02
AHETM_03
AHETM_04
AHETM_05
AHETM_06
Heterosexual females
AHETF_01
AHETF_02
AHETF_03
AHETF_04
AHETF_05
AHETF_06
Other
AOTHS_01
AOTHS_02
AOTHS_03
AOTHS_04
AOTHS_05
AOTHS_06
Unknown
AUNKS_01
AUNKS_02
AUNKS_03
AUNKS_04
AUNKS_05
AUNKS_06
Total
ATOT_01 (C)
ATOT_02 (C)
ATOT_03 (C)
ATOT_04 (C)
ATOT_05 (C)
ATOT_06 (C)
Table Footnotes
1. Includes persons, regardless of age, who attended at least one medical appointment at the STD Clinic during the
reporting period, either in-person or a telehealth visit.
19
2. Includes HIV tests that are supported in any way by PS20-2010-funded resources (e.g., funding, test kits, personnel,
training and technical assistance, laboratory support, electronic medical record enhancements) or other resources
available to the STD Clinic.
3. Includes persons who had a positive or negative test result.
4. Includes newly and previously diagnosed infections - includes all confirmed, self-reported, or provider-reported
HIV- positive persons as of the end of the report period.
5. Includes newly identified HIV diagnosis that have been confirmed either by the state surveillance system or
medical records available to the STD Clinic. For persons included in this column, the HIV surveillance system or
medical records are checked and/or 1) no prior report of HIV diagnosis is found, and 2) there is no indication of a
previous diagnosis by either client self- report (if the client was asked) or review of other data sources (if other data
sources were checked).
6. Includes self-report and provider report of new HIV diagnosis only, to collect data on persons diagnosed at other
clinics. If HIV diagnoses confirmed by lab or surveillance data, person should be reported in Column E only.
7. ‘Transgender’ includes all persons whose gender identity or expression is different from their sex assigned at
birth. Transgender persons may self-identify as transgender female or transgender woman, transgender male or
transgender man, or other gender non-binary person.
8. Race and ethnicity are to be collected at the local level in accordance with OMB standards
(https://www.govinfo.gov/ content/pkg/FR-1997-10-30/pdf/97-28653.pdf) and reported to CDC in the aggregate
using these categories. Hispanic or Latino persons can be of any race.
Table Definitions
(A) Total Number of Persons Served:
Includes all persons who received at least one (or more) clinical, laboratory, treatment, or diagnostic
services at the STD Clinic during the reporting period.
(B) Total Number of Persons Tested for HIV:
Includes persons who provided a specimen for a POC or laboratory test for HIV [all assays] at the
STD Clinic during the report period regardless of the result.
(C) Number of HIV-positive Persons Served:
Includes all persons known to be HIV-positive either by self-report (with or without prior test history
at the STD Clinic), prior confirmed positive HIV test or person who received a positive test at the STD
Clinic during the reporting period.
(D) Number of Previously Diagnosed Persons (HIV) Served:
Includes all persons known to be HIV-positive either by self-report (with or without prior test history
at the STD Clinic), prior confirmed positive HIV test or person who received a positive test at the STD
Clinic prior to the current reporting period.
(E) Newly Diagnosed HIV-positive Persons:
Includes persons with no prior HIV-positive test history, or self-report of HIV-positive status in the
STD Clinic, who test positive for HIV during the report period (for Component C clinics – must be
confirmed by state HIV Surveillance unit).
(F) Newly Diagnosed HIV-positive Persons Identified by Self-Report:
Includes persons with no prior HIV-positive test history, or no prior self-report of HIV-positive status
in the STD Clinic, who self-report as HIV-positive during the report period.
20
Version 8
Table B: PrEP Domain
EHE Component C clinics report ALL columns and rows; non-Component C clinics report just
highlighted columns/rows. However, non-C clinics are welcome to report all these measures if they
can. (Variable names in individual cells are for reference only and not reported by clinics.)
Table B Pre-Exposure Prophylaxis
(A)
(B)
(C)
(D)
(E)
(F)
(G)
HIV-Negative
Persons1
Already taking
PrEP
Screened for
PrEP Need2,3
Eligible for PrEP
Referral4,5
Referred to
PrEP Provider6,7,8
Linked to a PrEP
Provider9,10
Prescribed PrEP
at/by STD clinic
11,12
Age Group
<15 Years
BLT15_01
BLT15_02
BLT15_03
BLT15_04
BLT15_05
BLT15_06
BLT15_07
15-19 Years
B1519_01
B1519_02
B1519_03
B1519_04
B1519_05
B1519_06
B1519_07
20-29 Years
B2029_01
B2029_02
B2029_03
B2029_04
B2029_05
B2029_06
B2029_07
30-65 Years
B3065_01
B3065_02
B3065_03
B3065_04
B3065_05
B3065_06
B3065_07
≥ 66 Years
B66_01
B66_02
B66_03
B66_04
B66_05
B66_06
B66_07
Unknown
BUNK_01
BUNK_02
BUNK_03
BUNK_04
BUNK_05
BUNK_06
BUNK_07
Gender
Cisgender Men
BM_01
BM_02
BM_03
BM_04
BM_05
BM_06
BM_07
Cisgender women
BF_01
BF_02
BF_03
BF_04
BF_05
BF_06
BF_07
Transgender13
BTG_01
BTG_02
BTG_03
BTG_04
BTG_05
BTG_06
BTG_07
Unknown
BUNKG_01
BUNKG_02
BUNKG_03
BUNKG_04
BUNKG_05
BUNKG_06
BUNKG_07
Race/Ethnicity
Hispanic or Latino14
BHISP_01
BHISP_02
BHISP_03
BHISP_04
BHISP_05
BHISP_06
BHISP_07
Not Hispanic or Latino
American Indian/Alaska
Native (Alone)
BAIAN_01
BAIAN_02
BAIAN_03
BAIAN_04
BAIAN_05
BAIAN_06
BAIAN_07
Asian (Alone)
BASIAN_01
BASIAN_02
BASIAN_03
BASIAN_04
BASIAN_05
BASIAN_06
BASIAN_07
Black/African American
(Alone)
BBLACK_01
BBLACK_02
BBLACK_03
BBLACK_04
BBLACK_05
BBLACK_06
BBLACK_07
Native Hawaiian/Pacific
Islander (Alone)
BNHPI_01
BNHPI_02
BNHPI_03
BNHPI_04
BNHPI_05
BNHPI_06
BNHPI_07
White (Alone)
BWHTE_01
BWHTE_02
BWHTE_03
BWHTE_04
BWHTE_05
BWHTE_06
BWHTE_07
Multi-race
BMULT_01
BMULT_02
BMULT_03
BMULT_04
BMULT_05
BMULT_06
BMULT_07
Unknown race/ethnicity
BUNKR_01
BUNKR_02
BUNKR_03
BUNKR_04
BUNKR_05
BUNKR_06
BUNKR_07
Population Group
MSM/IDU
BMSMID_01
BMSMID_02
BMSMID_03
BMSMID_04
BMSMID_05
BMSMID_06
BMSMID_07
MSM (Only)
BMSM_01
BMSM_02
BMSM_03
BMSM_04
BMSM_05
BMSM_06
BMSM_07
PWID
BPWID_01
BPWID_02
BPWID_03
BPWID_04
BPWID_05
BPWID_06
BPWID_07
Heterosexual males
BHETM_01
BHETM_02
BHETM_03
BHETM_04
BHETM_05
BHETM_06
BHETM_07
Heterosexual females
BHETF_01
BHETF_02
BHETF_03
BHETF_04
BHETF_05
BHETF_06
BHETF_07
Other
BOTHS_01
BOTHS_02
BOTHS_03
BOTHS_04
BOTHS_05
BOTHS_06
BOTHS_07
Unknown
BUNKS_01
BUNKS_02
BUNKS_03
BUNKS_04
BUNKS_05
BUNKS_06
BUNKS_07
Total
BTOT_01 (C)
BTOT_02 (C)
BTOT_03 (C)
BTOT_04 (C)
BTOT_05 (C)
BTOT_06 (C)
BTOT_07 (C)
Table Footnotes
1. Include all HIV-negative persons who were eligible to receive HIV testing or PrEP services (e.g., screening, referral,
linkage, prescription) that are in any way supported by PS20-2010 or other funds; include all HIV-negative persons
regardless of current PrEP status.
2. Screening for PrEP eligibility is the process of conducting an initial assessment regarding a person’s eligibility (e.g.,
behavioral risk screening) for pre-exposure prophylaxis (PrEP) and determining whether a more thorough evaluation is
warranted. A person is screened if an initial assessment of eligibility for PrEP services is completed. For further
discussion on PrEP screening, see Centers for Disease Control and Prevention: US Public Health Service: Preexposure
prophylaxis for the prevention of HIV infection in the United States—2021 Update: A Clinical Practice Guideline.
https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2021.pdf. Published December 2021.
3. Denominator is Column A (number of HIV-negative persons) minus Column B. Note: All persons reflected in Column
B (those already on PrEP) should also be reflected in Column A because they are HIV negative.
21
Version 8
4. Persons eligible for PrEP Referral are those who meet the appropriate criteria and have completed the screening
steps above; specifically, whether he/she/they are HIV-negative and at substantial risk for HIV, as defined locally or by
CDC guidelines for PrEP, or are HIV-negative and requesting PrEP.
5. Persons reported as eligible for PrEP referral are those who have sexual or drug risk behaviors. These persons are
HIV- negative and should also be reported in Column A.
6. Referral to a PrEP provider external to the STD clinic is a process involving the provision of information on who the
providers are, what documents referred person should take with them, how to get to the providers’ agency, and what
to expect from the referral process.
7. If the clinic provides PrEP in-house and does not refer patients to external providers, cells in this column would be
zero. If the clinic has a co-located PrEP provider (i.e., a CBO doing PrEP, Ryan White HIV Clinic or other agency not
fiscally related to the STD clinic) referral to that specific practitioner could count as a PrEP referral and would be
recorded in this column.
8. Persons who are referred to PrEP provider should also be reflected in the counts reported for columns A & C.
9. Linkage to PrEP provider is the process through which a person at risk for becoming infected with HIV is helped to
access a healthcare provider who offers evaluation and management for PrEP. Linked to a PrEP provider refers to the
outcome of the referral or linkage of a PrEP eligible person to a PrEP provider, as indicated by the person’s attendance
at the first appointment and verified through reviews of medical records or other data systems or self-report by the
client. Includes persons linked to a PrEP provider external to the STD clinic and persons linked to a PrEP provider
internal to the STD clinic.
10. Persons who are linked to a PrEP provider should also be reflected in the counts reported for columns A, C & D.
11. Prescribed PrEP refers to a person who has been adequately evaluated and received an initial prescription for PrEP
at the STD clinic. If multiple prescriptions are provided to a patient during the reporting period, only the initial
prescription provided at the STD clinic should be reported.
12. Persons who are prescribed PrEP should also be reflected in the counts reported for columns A, C, D & E as
appropriate.
12. ‘Transgender’ includes all persons whose gender identity or expression is different from their sex assigned at
birth. Transgender persons may self-identify as transgender female or transgender woman, transgender male or
transgender man, or other gender non-binary person.
13. Race and ethnicity are to be collected at the local level in accordance with OMB standards
(https://www.govinfo.gov/ content/pkg/FR-1997-10-30/pdf/97-28653.pdf) and reported to CDC in the aggregate using
these categories. Hispanic or Latino persons can be of any race.
Definitions
(A) HIV-Negative Persons:
Includes all persons not known to be HIV-positive either by self-report (with or without prior
negative test history at the STD Clinic), with prior confirmed negative HIV test in the current report
period or person who received a negative test at the STD Clinic prior to the current reporting
period and no additional testing or history is available.
(B) Persons Already Taking PrEP:
Includes persons with no prior HIV-positive test history, conferment HIV-negative test or self-
report of HIV-negative status in the STD Clinic, who report taking PrEP, or are documented in
medical record as currently prescribed PrEP and on appropriate monitoring in the current
reporting period.
(C) Persons Screened for PrEP need:
Includes HIV-negative persons (see above) who completed an assessment of eligibility for PrEP
services
during
the
current
report
period.
(For
more
information,
see
https://www.cdc.gov/hiv/effective-interventions/prevent/prep/index.html.) Screening is the first
phase in the delivery of PrEP. The screening phase includes the steps engagement, navigation, and
an initial clinical evaluation.
22
Version 8
• Engagement includes an HIV risk assessment to identify persons who may benefit from PrEP.
It also includes education about PrEP basics, including how PrEP works, the importance of
medication adherence, and medication side effects.
• Navigation services should be offered at the time of PrEP engagement to guide persons in
need of PrEP to clinical services and insurance options that will pay for PrEP. If the client does
not have insurance, navigators or clinic staff should assist the client in obtaining insurance or
access to medication assistance programs.
• The initial clinical evaluation is the final step in the screening phase and is performed by a
medical provider. It occurs before prescribing PrEP and includes a brief history, including signs
or symptoms of acute HIV or sexually transmitted diseases (STDs), history of kidney disease, a
medication review and an assessment of indications for PrEP. The provider also should
conduct an HIV blood test, evaluate kidney function, check hepatitis B virus (HBV) and
hepatitis C virus (HCV) serology, test for STDs, and conduct a pregnancy test for women.
(D) Persons Eligible for PrEP Referral:
Eligible for PrEP are those who meet the appropriate criteria and have completed the screening steps
above; specifically, HIV-negative and at substantial risk for HIV, as defined locally or by CDC guidelines
for
PrEP
(https://www.cdc.gov/hiv/effective-interventions/prevent/prep/index.html).
Includes
persons who are HIV-negative and requesting PrEP.
(E) Persons Referred to External PrEP Provider:
Includes persons provided information on who the external PrEP providers are, what documents the
referred person should take with them, how to get to the providers’ agency, and what to expect from
the referral process. This category should include those referred to external PrEP providers. If the
clinic provides PrEP in-house and does not refer patients to external providers, cells in this column
would be zero. If the clinic has a co-located PrEP provider (i.e., a CBO doing PrEP, Ryan White HIV
Clinic or other agency NOT fiscally related to the STD clinic) referral to that specific practitioner could
count as a PrEP referral and would be recorded in this column.
(F) Persons Linked to PrEP Provider:
Includes persons helped to access a provider (either in-house or based on external referral) and who
successfully access this provider as documented by verified attendance at an appointment.
Verification can be by direct contact with the provider, or by patient self-report of attendance at an
appointment for those referred to external providers.
(G) Persons Prescribed PrEP in the STD Clinic:
Includes persons who were adequately evaluated and received a prescription for PrEP at the STD
clinic. Information may come from EHR or pharmacy records.
23
Version 8
Table C: STD Testing/Screening Domain
EHE Component C clinics report ALL columns and rows; non-Component C clinics report just
highlighted columns/rows). However, non-C clinics are welcome to report all these measures if they
can. (Variable names in individual cells are for reference only and not reported by clinics.)
Table C Rectal STD Screening and Testing
(A)
(B)
Total Number of
Persons Tested
for rectal GC/CT
Total number of
persons testing
positive for rectal
GC/CT
Age Group
N
N
<15 Years
CLT15_01
CLT15_02
15-19 Years
C1519_01
C1519_02
20-29 Years
C2029_01
C2029_02
30-65 Years
C3065_01
C3065_02
≥ 66 Years
C66_01
C66_02
Unknown
CUNK_01
CUNK_02
Gender
Cisgender Men
CM_01
CM_02
Cisgender women
CF_01
CF_02
Transgender1
CTG_01
CTG_02
Unknown
CUNKG_01
CUNKG_02
Race/Ethnicity
Hispanic or Latino
CHISP_01
CHISP_02
Not Hispanic or Latino
American Indian/Alaska
Native (Alone)
CAIAN_01
CAIAN_02
Asian (Alone)
CASIAN_01
CASIAN_02
Black/African American
(Alone)
CBLACK_01
CBLACK_02
Native Hawaiian/Pacific
Islander (Alone)
CNHPI_01
CNHPI_02
White (Alone)
CWHTE_01
CWHTE_02
Multi-race
CMULT_01
CMULT_02
Unknown race/ethnicity
CUNKR_01
CUNKR_02
Population Group
MSM/IDU
CMSMID_01
CMSMID_02
MSM (Only)
CMSM_01
CMSM_02
PWID
CPWID_01
CPWID_02
Heterosexual males
CHETM_01
CHETM_02
Heterosexual females
CHETF_01
CHETF_02
Other
COTHS_01
COTHS_02
Unknown
CUNKS_01
CUNKS_02
Total
CTOT_01 (C)
CTOT_02 (C)
24
Version 8
Table Footnotes
1. ‘Transgender’ includes all persons whose gender identity or expression is different from their sex assigned at
birth. Transgender persons may self-identify as transgender female or transgender woman, transgender male
or transgender man, or other gender non-binary person.
Table Definitions
(A) Total Number of Persons Tested for Rectal GC/CT
Includes all persons who were tested for GC/CT at the rectal anatomic site. Can be obtained from
laboratory data or, if documented uniformly, from visit data.
Total Number of Persons Testing Positive for Rectal GC/CT
Includes all persons who were tested for GC/CT at the rectal anatomic site and found to be positive.
Can be obtained from laboratory data or, if documented uniformly, from visit data.
25
Version 8
Appendix 3: Data Dictionary (CDC Use)
Clinic Capacity Dataset
DE #
VarName
Description
Type
Len
Reported
by
Header
1
DCLINID_01
Clinic identifier
Char
15
All
2
RSDTE_01
Report start date
Date
8
All
3
REDTE_01
Report end date
Date
8
All
4
RREPDTE_01
Date of report to CDC
Date
8
All
Clinic Service Capacity Domains
5
prev1
For the reporting period, did your clinic provide this service?
0 = No
1 = Yes
Num
1
All
6
prev1a
Brief description of changes for this reporting period [open comment]
Char
255
All
7
prev2
For the reporting period, did your clinic provide this service?
0 = No
1 = Yes
Num
1
All
8
prev2a
Brief description of changes for this reporting period [open comment]
Char
255
All
9
prev3
For the reporting period, did your clinic provide this service?
0 = No
1 = Yes
Num
1
All
10
prev3a
Brief description of changes for this reporting period [open comment]
Char
255
All
11
prev4
For the reporting period, did your clinic provide this service?
0 = No
1 = Yes
Num
1
All
12
prev4a
Brief description of changes for this reporting period [open comment]
Char
255
All
13
prev5
For the reporting period, did your clinic provide this service?
0 = No
1 = Yes
Num
1
All
14
prev5a
Brief description of changes for this reporting period [open comment]
Char
255
All
15
prev6
For the reporting period, did your clinic provide this service?
0 = No
1 = Yes
Num
1
All
16
prev6a
Brief description of changes for this reporting period [open comment]
Char
255
All
17
lab1
For the reporting period, did your clinic provide this service?
0 = No
1 = Yes
Num
1
All
18
lab1a
Brief description of changes for this reporting period [open comment]
Char
255
All
19
lab2
For the reporting period, did your clinic provide this service?
0 = No
1 = Yes
Num
1
All
20
lab2a
Brief description of changes for this reporting period [open comment]
Char
255
All
21
lab3
For the reporting period, did your clinic provide this service?
0 = No
1 = Yes
Num
1
All
22
lab3a
Brief description of changes for this reporting period [open comment]
Char
255
All
23
lab4
For the reporting period, did your clinic provide this service?
0 = No
1 = Yes
Num
1
All
24
lab4a
Brief description of changes for this reporting period [open comment]
Char
255
All
25
lab5
For the reporting period, did your clinic provide this service?
0 = No
1 = Yes
Num
1
All
26
lab5a
Brief description of changes for this reporting period [open comment]
Char
255
All
26
Version 8
27
treat1
For the reporting period, did your clinic provide this service?
0 = No
1 = Yes
Num
1
All
28
treat1a
Brief description of changes for this reporting period [open comment]
Char
255
All
29
treat2
For the reporting period, did your clinic provide this service?
0 = No
1 = Yes
Num
1
All
30
treat2a
Brief description of changes for this reporting period [open comment]
Char
255
All
31
treat3
For the reporting period, did your clinic provide this service?
0 = No
1 = Yes
Num
1
All
32
treat3a
Brief description of changes for this reporting period [open comment]
Char
255
All
33
treat4
For the reporting period, did your clinic provide this service?
0 = No
1 = Yes
Num
1
All
34
treat4a
Brief description of changes for this reporting period [open comment]
Char
255
All
35
treat5
For the reporting period, did your clinic provide this service?
0 = No
1 = Yes
Num
1
All
36
treat5a
Brief description of changes for this reporting period [open comment]
Char
255
All
37
treat6
For the reporting period, did your clinic provide this service?
0 = No
1 = Yes
Num
1
All
38
treat6a
Brief description of changes for this reporting period [open comment]
Char
255
All
39
serv1
For the reporting period, did your clinic provide this service?
0 = No
1 = Yes
Num
1
All
40
serv1a
Brief description of changes for this reporting period [open comment]
Char
255
All
41
serv2
For the reporting period, did your clinic provide this service?
0 = No
1 = Yes
Num
1
All
42
serv2a
Brief description of changes for this reporting period [open comment]
Char
255
All
43
serv3
For the reporting period, did your clinic provide this service?
0 = No
1 = Yes
Num
1
All
44
serv3a
Brief description of changes for this reporting period [open comment]
Char
255
All
45
serv4
For the reporting period, did your clinic provide this service?
0 = No
1 = Yes
Num
1
All
46
serv4a
Brief description of changes for this reporting period [open comment]
Char
255
All
47
serv5
For the reporting period, did your clinic provide this service?
0 = No
1 = Yes
Num
1
All
48
serv5a
Brief description of changes for this reporting period [open comment]
Char
255
All
49
open
Optional: Any other information about clinic capacity you wish to provide at this
time [open comment]
Char
255
All
Patient Outcomes Dataset
DE #
VarName
Description
Type
Len
Reported
by
Header
1
DCLINID_01
Clinic identifier
Char
15
All
2
RSDTE_01
Report start date
Date
8
All
3
REDTE_01
Report end date
Date
8
All
4
RREPDTE_01
Date of report to CDC
Date
8
All
27
Version 8
Table A
5
ALT15_01
Total Number of Persons <15 Served
Num
5
Comp C
only
6
A1519_01
Total Number of Persons 15-19 Served
Num
5
Comp C
only
7
A2029_01
Total Number of Persons 20-29 Served
Num
5
Comp C
only
8
A3065_01
Total Number of Persons 30-65 Served
Num
5
Comp C
only
9
A66_01
Total Number of Persons >65 Served
Num
5
Comp C
only
10
AUNK_01
Total Number of Persons with unknown age Served
Num
5
Comp C
only
11
ALT15_02
Total Number of Persons <15 Tested
Num
5
Comp C
only
12
A1519_02
Total Number of Persons 15-19 Tested
Num
5
Comp C
only
13
A2029_02
Total Number of Persons 20-29 Tested
Num
5
Comp C
only
14
A3065_02
Total Number of Persons 30-65 Tested
Num
5
Comp C
only
15
A66_02
Total Number of Persons >65 Tested
Num
5
Comp C
only
16
AUNK_02
Total Number of Persons with unknown age Tested
Num
5
Comp C
only
17
ALT15_03
Total Number of HIV-positive Persons <15
Num
5
Comp C
only
18
A1519_03
Total Number of HIV-positive Persons 15-19
Num
5
Comp C
only
19
A2029_03
Total Number of HIV-positive Persons 20-29
Num
5
Comp C
only
20
A3065_03
Total Number of HIV-positive Persons 30-65
Num
5
Comp C
only
21
A66_03
Total Number of HIV-positive Persons >65
Num
5
Comp C
only
22
AUNK_03
Total Number of HIV-positive Persons of Unknown Age
Num
5
Comp C
only
23
ALT15_04
Total Number of Previously Diagnosed Persons <15
Num
5
Comp C
only
24
A1519_04
Total Number of Previously Diagnosed Persons 15-19
Num
5
Comp C
only
25
A2029_04
Total Number of Previously Diagnosed Persons 20-29
Num
5
Comp C
only
26
A3065_04
Total Number of Previously Diagnosed Persons 30-65
Num
5
Comp C
only
27
A66_04
Total Number of Previously Diagnosed Persons >65
Num
5
Comp C
only
28
AUNK_04
Total Number of Previously Diagnosed Persons of Unknown Age
Num
5
Comp C
only
29
ALT15_05
Total Number of Newly Diagnosed Persons <15
Num
5
Comp C
only
30
A1519_05
Total Number of Newly Diagnosed Persons 15-19
Num
5
Comp C
only
31
A2029_05
Total Number of Newly Diagnosed Persons 20-29
Num
5
Comp C
only
32
A3065_05
Total Number of Newly Diagnosed Persons 30-65
Num
5
Comp C
only
33
A66_05
Total Number of Newly Diagnosed Persons >65
Num
5
Comp C
only
34
AUNK_05
Total Number of Newly Diagnosed Persons of Unknown Age
Num
5
Comp C
only
35
ALT15_06
Total Number of Newly Diagnosed Persons <15 by Self Report
Num
5
Comp C
only
36
A1519_06
Total Number of Newly Diagnosed Persons 15-19 by Self Report
Num
5
Comp C
only
37
A2029_06
Total Number of Newly Diagnosed Persons 20-29 by Self Report
Num
5
Comp C
only
28
Version 8
38
A3065_06
Total Number of Newly Diagnosed Persons 30-65 by Self Report
Num
5
Comp C
only
39
A66_06
Total Number of Newly Diagnosed Persons >65 by Self Report
Num
5
Comp C
only
40
AUNK_06
Total Number of Newly Diagnosed Persons of Unknown Age by Self Report
Num
5
Comp C
only
41
AM_01
Total Number of Males Served
Num
5
All
42
AF_01
Total Number of Females Served
Num
5
All
43
ATG_01
Total Number of Transgender Served
Num
5
All
44
AUNKG_01
Total Number of Unk Gender Served
Num
5
All
45
AM_02
Total Number of Males Tested
Num
5
All
46
AF_02
Total Number of Females Tested
Num
5
All
47
ATG_02
Total Number of Transgender Tested
Num
5
All
48
AUNKG_02
Total Number of Unk Gender Tested
Num
5
All
49
AM_03
Total Number of HIV-positive Males
Num
5
Comp C
only
50
AF_03
Total Number of HIV-positive Females
Num
5
Comp C
only
51
ATG_03
Total Number of HIV-positive Transgender
Num
5
Comp C
only
52
AUNKG_03
Total Number of HIV-positive Unk Gender
Num
5
Comp C
only
53
AM_04
Total Number of Previously Diagnosed Males
Num
5
All
54
AF_04
Total Number of Previously Diagnosed Females
Num
5
All
55
ATG_04
Total Number of Previously Diagnosed Transgender
Num
5
All
56
AUNKG_04
Total Number of Previously Diagnosed Unk Gender
Num
5
All
57
AM_05
Total Number of Newly Diagnosed Males
Num
5
Comp C
only
58
AF_05
Total Number of Newly Diagnosed Females
Num
5
Comp C
only
59
ATG_05
Total Number of Newly Diagnosed Transgender
Num
5
Comp C
only
60
AUNKG_05
Total Number of Newly Diagnosed Unk Gender
Num
5
Comp C
only
61
AM_06
Total Number of Males Newly Diagnosed by Self Report
Num
5
All
62
AF_06
Total Number of Females Newly Diagnosed by Self Report
Num
5
All
63
ATG_06
Total Number of Transgender Newly Diagnosed by Self Report
Num
5
All
64
AUNKG_06
Total Number of Unk Gender Newly Diagnosed by Self Report
Num
5
All
65
AHISP_01
Total Number of Hispanics/Latino Served
Num
5
All
66
AAIAN_01
Total Number of NH-AIAN Served
Num
5
All
67
AASIAN_01
Total Number of NH-Asian Served
Num
5
All
68
ABLACK_01
Total Number of NH-Black Served
Num
5
All
69
ANHPI_01
Total Number of NH-NHOPI Served
Num
5
All
70
AWHTE_01
Total Number of NH-White Served
Num
5
All
71
AMULT_01
Total Number of NH-Multi-Race Served
Num
5
All
72
AUNKR_01
Total Number of NH-Unk-Race Served
Num
5
All
73
AHISP_02
Total Number of Hispanics/Latino Tested
Num
5
All
74
AAIAN_02
Total Number of NH-AIAN Tested
Num
5
All
75
AASIAN_02
Total Number of NH-Asian Tested
Num
5
All
76
ABLACK_02
Total Number of NH-Black Tested
Num
5
All
29
Version 8
77
ANHPI_02
Total Number of NH-NHOPI Tested
Num
5
All
78
AWHTE_02
Total Number of NH-White Tested
Num
5
All
79
AMULT_02
Total Number of NH-Multi-Race Tested
Num
5
All
80
AUNKR_02
Total Number of NH-Unk-Race Tested
Num
5
All
81
AHISP_03
Total Number of Hispanics/Latino HIV-Positive
Num
5
Comp C
only
82
AAIAN_03
Total Number of NH-AIAN HIV-Positive
Num
5
Comp C
only
83
AASIAN_03
Total Number of NH-Asian HIV-Positive
Num
5
Comp C
only
84
ABLACK_03
Total Number of NH-Black HIV-Positive
Num
5
Comp C
only
85
ANHPI_03
Total Number of NH-NHOPI HIV-Positive
Num
5
Comp C
only
86
AWHTE_03
Total Number of NH-White HIV-Positive
Num
5
Comp C
only
87
AMULT_03
Total Number of NH-Multi-Race HIV-Positive
Num
5
Comp C
only
88
AUNKR_03
Total Number of NH-Unk-Race HIV-Positive
Num
5
Comp C
only
89
AHISP_04
Total Number of Hispanics/Latino Previously Diagnosed
Num
5
All
90
AAIAN_04
Total Number of NH-AIAN Previously Diagnosed
Num
5
All
91
AASIAN_04
Total Number of NH-Asian Previously Diagnosed
Num
5
All
92
ABLACK_04
Total Number of NH-Black Previously Diagnosed
Num
5
All
93
ANHPI_04
Total Number of NH-NHOPI Previously Diagnosed
Num
5
All
94
AWHTE_04
Total Number of NH-White Previously Diagnosed
Num
5
All
95
AMULT_04
Total Number of NH-Multi-Race Previously Diagnosed
Num
5
All
96
AUNKR_04
Total Number of NH-Unk-Race Previously Diagnosed
Num
5
All
97
AHISP_05
Total Number of Hispanics/Latino Newly Diagnosed
Num
5
Comp C
only
98
AAIAN_05
Total Number of NH-AIAN Newly Diagnosed
Num
5
Comp C
only
99
AASIAN_05
Total Number of NH-Asian Newly Diagnosed
Num
5
Comp C
only
100
ABLACK_05
Total Number of NH-Black Newly Diagnosed
Num
5
Comp C
only
101
ANHPI_05
Total Number of NH-NHOPI Newly Diagnosed
Num
5
Comp C
only
102
AWHTE_05
Total Number of NH-White Newly Diagnosed
Num
5
Comp C
only
103
AMULT_05
Total Number of NH-Multi-Race Newly Diagnosed
Num
5
Comp C
only
104
AUNKR_05
Total Number of NH-Unk-Race Newly Diagnosed
Num
5
Comp C
only
105
AHISP_06
Total Number of Hispanics/Latino Newly Diagnosed by Self Report
Num
5
All
106
AAIAN_06
Total Number of NH-AIAN Newly Diagnosed by Self Report
Num
5
All
107
AASIAN_06
Total Number of NH-Asian Newly Diagnosed by Self Report
Num
5
All
108
ABLACK_06
Total Number of NH-Black Newly Diagnosed by Self Report
Num
5
All
109
ANHPI_06
Total Number of NH-NHOPI Newly Diagnosed by Self Report
Num
5
All
110
AWHTE_06
Total Number of NH-White Newly Diagnosed by Self Report
Num
5
All
111
AMULT_06
Total Number of NH-Multi-Race Newly Diagnosed by Self Report
Num
5
All
112
AUNKR_06
Total Number of NH-Unk-Race Newly Diagnosed by Self Report
Num
5
All
113
AMSMID_01
Total Number of MSM/IDU Served
Num
5
Comp C
only
114
AMSM_01
Total Number of MSM Served
Num
5
All
30
Version 8
115
APWID_01
Total Number of PWID Served
Num
5
Comp C
only
116
AHETM_01
Total Number of Heterosexual Males Served
Num
5
Comp C
only
117
AHETF_01
Total Number of Heterosexual Females Served
Num
5
Comp C
only
118
AOTHS_01
Total Number of Other Pop. Served
Num
5
Comp C
only
119
AUNKS_01
Total Number of Unk Pop. Served
Num
5
Comp C
only
120
ATOT_01 (C)
Column Total – all Served
Num
5
121
AMSMID_02
Total Number of MSM/IDU Tested
Num
5
Comp C
only
122
AMSM_02
Total Number of MSM Tested
Num
5
All
123
APWID_02
Total Number of PWID Tested
Num
5
Comp C
only
124
AHETM_02
Total Number of Heterosexual Males Tested
Num
5
Comp C
only
125
AHETF_02
Total Number of Heterosexual Females Tested
Num
5
Comp C
only
126
AOTHS_02
Total Number of Other Pop. Tested
Num
5
Comp C
only
127
AUNKS_02
Total Number of Unk Pop. Tested
Num
5
Comp C
only
128
ATOT_02 (C)
Column Total – all Tested
Num
5
129
AMSMID_03
Total Number of MSM/IDU HIV-Positive
Num
5
Comp C
only
130
AMSM_03
Total Number of MSM HIV-Positive
Num
5
Comp C
only
131
APWID_03
Total Number of PWID HIV-Positive
Num
5
Comp C
only
132
AHETM_03
Total Number of Heterosexual Males HIV-Positive
Num
5
Comp C
only
133
AHETF_03
Total Number of Heterosexual Females HIV-Positive
Num
5
Comp C
only
134
AOTHS_03
Total Number of Other Pop. HIV-Positive
Num
5
Comp C
only
135
AUNKS_03
Total Number of Unk Pop. HIV-Positive
Num
5
Comp C
only
136
ATOT_03 (C)
Column Total – all HIV-Positive
Num
5
137
AMSMID_04
Total Number of MSM/IDU Previously Diagnosed
Num
5
Comp C
only
138
AMSM_04
Total Number of MSM Previously Diagnosed
Num
5
All
139
APWID_04
Total Number of PWID Previously Diagnosed
Num
5
Comp C
only
140
AHETM_04
Total Number of Heterosexual Males Previously Diagnosed
Num
5
Comp C
only
141
AHETF_04
Total Number of Heterosexual Females Previously Diagnosed
Num
5
Comp C
only
142
AOTHS_04
Total Number of Other Pop. Previously Diagnosed
Num
5
Comp C
only
143
AUNKS_04
Total Number of Unk Pop. Previously Diagnosed
Num
5
Comp C
only
144
ATOT_04 (C)
Column Total – all Previously Diagnosed
Num
5
145
AMSMID_05
Total Number of MSM/IDU Newly Diagnosed
Num
5
Comp C
only
146
AMSM_05
Total Number of MSM Newly Diagnosed
Num
5
Comp C
only
147
APWID_05
Total Number of PWID Newly Diagnosed
Num
5
Comp C
only
148
AHETM_05
Total Number of Heterosexual Males Newly Diagnosed
Num
5
Comp C
only
149
AHETF_05
Total Number of Heterosexual Females Newly Diagnosed
Num
5
Comp C
only
31
Version 8
150
AOTHS_05
Total Number of Other Pop. Newly Diagnosed
Num
5
Comp C
only
151
AUNKS_05
Total Number of Unk Pop. Newly Diagnosed
Num
5
Comp C
only
152
ATOT_05 (C)
Column Total – all Newly Diagnosed
Num
5
153
AMSMID_06
Total Number of MSM/IDU Newly Diagnosed by Self Report
Num
5
Comp C
only
154
AMSM_06
Total Number of MSM Newly Diagnosed by Self Report
Num
5
All
155
APWID_06
Total Number of PWID Newly Diagnosed by Self Report
Num
5
Comp C
only
156
AHETM_06
Total Number of Heterosexual Males Newly Diagnosed by Self Report
Num
5
Comp C
only
157
AHETF_06
Total Number of Heterosexual Females Newly Diagnosed by Self Report
Num
5
Comp C
only
158
AOTHS_06
Total Number of Other Pop. Newly Diagnosed by Self Report
Num
5
Comp C
only
159
AUNKS_06
Total Number of Unk Pop. Newly Diagnosed by Self Report
Num
5
Comp C
only
160
ATOT_06 (C)
Column Total – all Newly Diagnosed by Self Report
Num
5
Table B
161
BLT15_01
Total Number of HIV-Negative Persons <15
Num
5
Comp C
only
162
B1519_01
Total Number of HIV-Negative Persons 15-19
Num
5
Comp C
only
163
B2029_01
Total Number of HIV-Negative Persons 20-29
Num
5
Comp C
only
164
B3065_01
Total Number of HIV-Negative Persons 30-65
Num
5
Comp C
only
165
B66_01
Total Number of HIV-Negative Persons >65
Num
5
Comp C
only
166
BUNK_01
Total Number of HIV-Negative Persons with unknown age
Num
5
Comp C
only
167
BLT15_02
Total Number of HIV-Negative Persons <15 Already on PrEP
Num
5
Comp C
only
168
B1519_02
Total Number of HIV-Negative Persons 15-19 Already on PrEP
Num
5
Comp C
only
169
B2029_02
Total Number of HIV-Negative Persons 20-29 Already on PrEP
Num
5
Comp C
only
170
B3065_02
Total Number of HIV-Negative Persons 30-65 Already on PrEP
Num
5
Comp C
only
171
B66_02
Total Number of HIV-Negative Persons >65 Already on PrEP
Num
5
Comp C
only
172
BUNK_02
Total Number of HIV-Negative Persons with unknown age Already on PrEP
Num
5
Comp C
only
173
BLT15_03
Total Number of HIV-Negative Persons <15 Screened for PrEP
Num
5
Comp C
only
174
B1519_03
Total Number of HIV-Negative Persons 15-19 Screened for PrEP
Num
5
Comp C
only
175
B2029_03
Total Number of HIV-Negative Persons 20-29 Screened for PrEP
Num
5
Comp C
only
176
B3065_03
Total Number of HIV-Negative Persons 30-65 Screened for PrEP
Num
5
Comp C
only
177
B66_03
Total Number of HIV-Negative Persons >65 Screened for PrEP
Num
5
Comp C
only
178
BUNK_03
Total Number of HIV-Negative Persons with unknown age Screened for PrEP
Num
5
Comp C
only
179
BLT15_04
Total Number of HIV-Negative Persons <15 Eligible for PrEP Referral
Num
5
Comp C
only
180
B1519_04
Total Number of HIV-Negative Persons 15-19 Eligible for PrEP Referral
Num
5
Comp C
only
181
B2029_04
Total Number of HIV-Negative Persons 20-29 Eligible for PrEP Referral
Num
5
Comp C
only
182
B3065_04
Total Number of HIV-Negative Persons 30-65 Eligible for PrEP Referral
Num
5
Comp C
only
183
B66_04
Total Number of HIV-Negative Persons >65 Eligible for PrEP Referral
Num
5
Comp C
only
32
Version 8
184
BUNK_04
Total Number of HIV-Negative Persons with unknown age Eligible for PrEP
Referral4
Num
5
Comp C
only
185
BLT15_05
Total Number of HIV-Negative Persons <15 Referred to PrEP Provider
Num
5
Comp C
only
186
B1519_05
Total Number of HIV-Negative Persons 15-19 Referred to PrEP Provider
Num
5
Comp C
only
187
B2029_05
Total Number of HIV-Negative Persons 20-29 Referred to PrEP Provider
Num
5
Comp C
only
188
B3065_05
Total Number of HIV-Negative Persons 30-65 Referred to PrEP Provider
Num
5
Comp C
only
189
B66_05
Total Number of HIV-Negative Persons >65 Referred to PrEP Provider
Num
5
Comp C
only
190
BUNK_05
Total Number of HIV-Negative Persons with unknown age Referred to PrEP
Provider
Num
5
Comp C
only
191
BLT15_06
Total Number of HIV-Negative Persons <15 Linked to PrEP Provider
Num
5
Comp C
only
192
B1519_06
Total Number of HIV-Negative Persons 15-19 Linked to PrEP Provider
Num
5
Comp C
only
193
B2029_06
Total Number of HIV-Negative Persons 20-29 Linked to PrEP Provider
Num
5
Comp C
only
194
B3065_06
Total Number of HIV-Negative Persons 30-65 Linked to PrEP Provider
Num
5
Comp C
only
195
B66_06
Total Number of HIV-Negative Persons >65 Linked to PrEP Provider
Num
5
Comp C
only
196
BUNK_06
Total Number of HIV-Negative Persons with unknown age Linked to PrEP
Provider
Num
5
Comp C
only
197
BLT15_07
Total Number of HIV-Negative Persons <15 Prescribed PrEP at the STD Clinic
Num
5
Comp C
only
198
B1519_07
Total Number of HIV-Negative Persons 15-19 Prescribed PrEP at the STD Clinic
Num
5
Comp C
only
199
B2029_07
Total Number of HIV-Negative Persons 20-29 Prescribed PrEP at the STD Clinic
Num
5
Comp C
only
200
B3065_07
Total Number of HIV-Negative Persons 30-65 Prescribed PrEP at the STD Clinic
Num
5
Comp C
only
201
B66_07
Total Number of HIV-Negative Persons >65 Prescribed PrEP at the STD Clinic
Num
5
Comp C
only
202
BUNK_07
Total Number of HIV-Negative Persons with unknown age Prescribed PrEP at the
STD Clinic
Num
5
Comp C
only
203
BM_01
Total Number of HIV-Negative Males
Num
5
All
204
BF_01
Total Number of HIV-Negative Females
Num
5
All
205
BTG_01
Total Number of HIV-Negative Transgender
Num
5
All
206
BUNKG_01
Total Number of HIV-Negative Unk Gender
Num
5
All
207
BM_02
Total Number of HIV-Negative Males Already on PrEP
Num
5
All
208
BF_02
Total Number of HIV-Negative Females Already on PrEP
Num
5
All
209
BTG_02
Total Number of HIV-Negative Transgender Already on PrEP
Num
5
All
210
BUNKG_02
Total Number of HIV-Negative Unk Gender Already on PrEP
Num
5
All
211
BM_03
Total Number of HIV-Negative Males Screened for PrEP
Num
5
Comp C
only
212
BF_03
Total Number of HIV-Negative Females Screened for PrEP
Num
5
Comp C
only
213
BTG_03
Total Number of HIV-Negative Transgender Screened for PrEP
Num
5
Comp C
only
214
BUNKG_03
Total Number of HIV-Negative Unk Gender Screened for PrEP
Num
5
Comp C
only
215
BM_04
Total Number of HIV-Negative Males Eligible for PrEP Referral
Num
5
Comp C
only
216
BF_04
Total Number of HIV-Negative Females Eligible for PrEP Referral
Num
5
Comp C
only
217
BTG_04
Total Number of HIV-Negative Transgender Eligible for PrEP Referral
Num
5
Comp C
only
218
BUNKG_04
Total Number of HIV-Negative Unk Gender Eligible for PrEP Referral
Num
5
Comp C
only
219
BM_05
Total Number of HIV-Negative Males Referred to PrEP Provider
Num
5
All
33
Version 8
220
BF_05
Total Number of HIV-Negative Females Referred to PrEP Provider
Num
5
All
221
BTG_05
Total Number of HIV-Negative Transgender Referred to PrEP Provider
Num
5
All
222
BUNKG_05
Total Number of HIV-Negative Unk Gender Referred to PrEP Provider
Num
5
All
223
BM_06
Total Number of HIV-Negative Males Linked to PrEP Provider
Num
5
Comp C
only
224
BF_06
Total Number of HIV-Negative Females Linked to PrEP Provider
Num
5
Comp C
only
225
BTG_06
Total Number of HIV-Negative Transgender Linked to PrEP Provider
Num
5
Comp C
only
226
BUNKG_06
Total Number of HIV-Negative Unk Gender Linked to PrEP Provider
Num
5
Comp C
only
227
BM_07
Total Number of HIV-Negative Males Prescribed PrEP at the STD Clinic
Num
5
Comp C
only
228
BF_07
Total Number of HIV-Negative Females Prescribed PrEP at the STD Clinic
Num
5
Comp C
only
229
BTG_07
Total Number of HIV-Negative Transgender Prescribed PrEP at the STD Clinic
Num
5
Comp C
only
230
BUNKG_07
Total Number of HIV-Negative Unk Gender Prescribed PrEP at the STD Clinic
Num
5
Comp C
only
231
BHISP_01
Total Number of HIV-Negative Hispanics/Latinos
Num
5
All
232
BAIAN_01
Total Number of HIV-Negative NH-AIAN
Num
5
All
233
BASIAN_01
Total Number of HIV-Negative NH-Asian
Num
5
All
234
BBLACK_01
Total Number of HIV-Negative NH-Black
Num
5
All
235
BNHPI_01
Total Number of HIV-Negative NH-NHOPI
Num
5
All
236
BWHTE_01
Total Number of HIV-Negative NH-White
Num
5
All
237
BMULT_01
Total Number of HIV-Negative NH-Multi-Race
Num
5
All
238
BUNKR_01
Total Number of HIV-Negative NH-Unk-Race
Num
5
All
239
BHISP_02
Total Number of HIV-Negative Hispanics/Latinos Already on PrEP
Num
5
All
240
BAIAN_02
Total Number of HIV-Negative NH-AIAN Already on PrEP
Num
5
All
241
BASIAN_02
Total Number of HIV-Negative NH-Asian Already on PrEP
Num
5
All
242
BBLACK_02
Total Number of HIV-Negative NH-Black Already on PrEP
Num
5
All
243
BNHPI_02
Total Number of HIV-Negative NH-NHOPI Already on PrEP
Num
5
All
244
BWHTE_02
Total Number of HIV-Negative NH-White Already on PrEP
Num
5
All
245
BMULT_02
Total Number of HIV-Negative NH-Multi-Race Already on PrEP
Num
5
All
246
BUNKR_02
Total Number of HIV-Negative NH-Unk-Race Already on PrEP
Num
5
All
247
BHISP_03
Total Number of HIV-Negative Hispanics/Latinos Screened for PrEP
Num
5
Comp C
only
248
BAIAN_03
Total Number of HIV-Negative NH-AIAN Screened for PrEP
Num
5
Comp C
only
249
BASIAN_03
Total Number of HIV-Negative NH-Asian Screened for PrEP
Num
5
Comp C
only
250
BBLACK_03
Total Number of HIV-Negative NH-Black Screened for PrEP
Num
5
Comp C
only
251
BNHPI_03
Total Number of HIV-Negative NH-NHOPI Screened for PrEP
Num
5
Comp C
only
252
BWHTE_03
Total Number of HIV-Negative NH-White Screened for PrEP
Num
5
Comp C
only
253
BMULT_03
Total Number of HIV-Negative NH-Multi-Race Screened for PrEP
Num
5
Comp C
only
254
BUNKR_03
Total Number of HIV-Negative NH-Unk-Race Screened for PrEP
Num
5
Comp C
only
255
BHISP_04
Total Number of HIV-Negative Hispanics/Latinos Eligible for PrEP Referral
Num
5
Comp C
only
256
BAIAN_04
Total Number of HIV-Negative NH-AIAN Eligible for PrEP Referral
Num
5
Comp C
only
257
BASIAN_04
Total Number of HIV-Negative NH-Asian Eligible for PrEP Referral
Num
5
Comp C
only
34
Version 8
258
BBLACK_04
Total Number of HIV-Negative NH-Black Eligible for PrEP Referral
Num
5
Comp C
only
259
BNHPI_04
Total Number of HIV-Negative NH-NHOPI Eligible for PrEP Referral
Num
5
Comp C
only
260
BWHTE_04
Total Number of HIV-Negative NH-White Eligible for PrEP Referral
Num
5
Comp C
only
261
BMULT_04
Total Number of HIV-Negative NH-Multi-Race Eligible for PrEP Referral
Num
5
Comp C
only
262
BUNKR_04
Total Number of HIV-Negative NH-Unk-Race Eligible for PrEP Referral
Num
5
Comp C
only
263
BHISP_05
Total Number of HIV-Negative Hispanics/Latinos Referred to PrEP Provider
Num
5
All
264
BAIAN_05
Total Number of HIV-Negative NH-AIAN Referred to PrEP Provider
Num
5
All
265
BASIAN_05
Total Number of HIV-Negative NH-Asian Referred to PrEP Provider
Num
5
All
266
BBLACK_05
Total Number of HIV-Negative NH-Black Referred to PrEP Provider
Num
5
All
267
BNHPI_05
Total Number of HIV-Negative NH-NHOPI Referred to PrEP Provider
Num
5
All
268
BWHTE_05
Total Number of HIV-Negative NH-White Referred to PrEP Provider
Num
5
All
269
BMULT_05
Total Number of HIV-Negative NH-Multi-Race Referred to PrEP Provider
Num
5
All
270
BUNKR_05
Total Number of HIV-Negative NH-Unk-Race Referred to PrEP Provider
Num
5
All
271
BHISP_06
Total Number of HIV-Negative Hispanics/Latinos Linked to PrEP Provider
Num
5
Comp C
only
272
BAIAN_06
Total Number of HIV-Negative NH-AIAN Linked to PrEP Provider
Num
5
Comp C
only
273
BASIAN_06
Total Number of HIV-Negative NH-Asian Linked to PrEP Provider
Num
5
Comp C
only
274
BBLACK_06
Total Number of HIV-Negative NH-Black Linked to PrEP Provider
Num
5
Comp C
only
275
BNHPI_06
Total Number of HIV-Negative NH-NHOPI Linked to PrEP Provider
Num
5
Comp C
only
276
BWHTE_06
Total Number of HIV-Negative NH-White Linked to PrEP Provider
Num
5
Comp C
only
277
BMULT_06
Total Number of HIV-Negative NH-Multi-Race Linked to PrEP Provider
Num
5
Comp C
only
278
BUNKR_06
Total Number of HIV-Negative NH-Unk-Race Linked to PrEP Provider
Num
5
Comp C
only
279
BHISP_07
Total Number of HIV-Negative Hispanics/Latinos Prescribed PrEP at the STD
Clinic
Num
5
Comp C
only
280
BAIAN_07
Total Number of HIV-Negative NH-AIAN Prescribed PrEP at the STD Clinic
Num
5
Comp C
only
281
BASIAN_07
Total Number of HIV-Negative NH-Asian Prescribed PrEP at the STD Clinic
Num
5
Comp C
only
282
BBLACK_07
Total Number of HIV-Negative NH-Black Prescribed PrEP at the STD Clinic
Num
5
Comp C
only
283
BNHPI_07
Total Number of HIV-Negative NH-NHOPI Prescribed PrEP at the STD Clinic
Num
5
Comp C
only
284
BWHTE_07
Total Number of HIV-Negative NH-White Prescribed PrEP at the STD Clinic
Num
5
Comp C
only
285
BMULT_07
Total Number of HIV-Negative NH-Multi-Race Prescribed PrEP at the STD Clinic
Num
5
Comp C
only
286
BUNKR_07
Total Number of HIV-Negative NH-Unk-Race Prescribed PrEP at the STD Clinic
Num
5
Comp C
only
287
BMSMID_01
Total Number of HIV-Negative MSM/IDU
Num
5
Comp C
only
288
BMSM_01
Total Number of HIV-Negative MSM
Num
5
All
289
BPWID_01
Total Number of HIV-Negative PWID
Num
5
Comp C
only
290
BHETM_01
Total Number of HIV-Negative Heterosexual Males
Num
5
Comp C
only
291
BHETF_01
Total Number of HIV-Negative Heterosexual Females
Num
5
Comp C
only
292
BOTHS_01
Total Number of HIV-Negative Other Pop.
Num
5
Comp C
only
293
BUNKS_01
Total Number of HIV-Negative Unk Pop.
Num
5
Comp C
only
35
Version 8
294
BTOT_01 (C)
Column Total – all HIV-Negative
Num
5
295
BMSMID_02
Total Number of HIV-Negative MSM/IDU Already on PrEP
Num
5
Comp C
only
296
BMSM_02
Total Number of HIV-Negative MSM Already on PrEP
Num
5
All
297
BPWID_02
Total Number of HIV-Negative PWID Already on PrEP
Num
5
Comp C
only
298
BHETM_02
Total Number of HIV-Negative Heterosexual Males Already on PrEP
Num
5
Comp C
only
299
BHETF_02
Total Number of HIV-Negative Heterosexual Females Already on PrEP
Num
5
Comp C
only
300
BOTHS_02
Total Number of HIV-Negative Other Pop. Already on PrEP
Num
5
Comp C
only
301
BUNKS_02
Total Number of HIV-Negative Unk Pop. Already on PrEP
Num
5
Comp C
only
302
BTOT_02 (C)
Column Total – all HIV-Negative Already on PrEP
Num
5
303
BMSMID_03
Total Number of HIV-Negative MSM/IDU Screened for PrEP
Num
5
Comp C
only
304
BMSM_03
Total Number of HIV-Negative MSM Screened for PrEP
Num
5
Comp C
only
305
BPWID_03
Total Number of HIV-Negative PWID Screened for PrEP
Num
5
Comp C
only
306
BHETM_03
Total Number of HIV-Negative Heterosexual Males Screened for PrEP
Num
5
Comp C
only
307
BHETF_03
Total Number of HIV-Negative Heterosexual Females Screened for PrEP
Num
5
Comp C
only
308
BOTHS_03
Total Number of HIV-Negative Other Pop. Screened for PrEP
Num
5
Comp C
only
309
BUNKS_03
Total Number of HIV-Negative Unk Pop. Screened for PrEP
Num
5
Comp C
only
310
BTOT_03 (C)
Column Total – all HIV-Negative Screened for PrEP
Num
5
311
BMSMID_04
Total Number of HIV-Negative MSM/IDU Eligible for PrEP Referral
Num
5
Comp C
only
312
BMSM_04
Total Number of HIV-Negative MSM Eligible for PrEP Referral
Num
5
Comp C
only
313
BPWID_04
Total Number of HIV-Negative PWID Eligible for PrEP Referral
Num
5
Comp C
only
314
BHETM_04
Total Number of HIV-Negative Heterosexual Males Eligible for PrEP Referral
Num
5
Comp C
only
315
BHETF_04
Total Number of HIV-Negative Heterosexual Females Eligible for PrEP Referral
Num
5
Comp C
only
316
BOTHS_04
Total Number of HIV-Negative Other Pop. Eligible for PrEP Referral
Num
5
Comp C
only
317
BUNKS_04
Total Number of HIV-Negative Unk Pop. Eligible for PrEP Referral
Num
5
Comp C
only
318
BTOT_04 (C)
Column Total – all HIV-Negative Eligible for PrEP Referral
Num
5
319
BMSMID_05
Total Number of HIV-Negative MSM/IDU Referred to PrEP Provider
Num
5
Comp C
only
320
BMSM_05
Total Number of HIV-Negative MSM Referred to PrEP Provider
Num
5
All
321
BPWID_05
Total Number of HIV-Negative PWID Referred to PrEP Provider
Num
5
Comp C
only
322
BHETM_05
Total Number of HIV-Negative Heterosexual Males Referred to PrEP Provider
Num
5
Comp C
only
323
BHETF_05
Total Number of HIV-Negative Heterosexual Females Referred to PrEP Provider
Num
5
Comp C
only
324
BOTHS_05
Total Number of HIV-Negative Other Pop. Referred to PrEP Provider
Num
5
Comp C
only
325
BUNKS_05
Total Number of HIV-Negative Unk Pop. Referred to PrEP Provider
Num
5
Comp C
only
326
BTOT_05 (C)
Column Total – all HIV-Negative Referred to PrEP Provider
Num
5
327
BMSMID_06
Total Number of HIV-Negative MSM/IDU Linked to PrEP Provider
Num
5
Comp C
only
328
BMSM_06
Total Number of HIV-Negative MSM Linked to PrEP Provider
Num
5
Comp C
only
36
Version 8
329
BPWID_06
Total Number of HIV-Negative PWID Linked to PrEP Provider
Num
5
Comp C
only
330
BHETM_06
Total Number of HIV-Negative Heterosexual Males Linked to PrEP Provider
Num
5
Comp C
only
331
BHETF_06
Total Number of HIV-Negative Heterosexual Females Linked to PrEP Provider
Num
5
Comp C
only
332
BOTHS_06
Total Number of HIV-Negative Other Pop. Linked to PrEP Provider
Num
5
Comp C
only
333
BUNKS_06
Total Number of HIV-Negative Unk Pop. Linked to PrEP Provider
Num
5
Comp C
only
334
BTOT_06 (C)
Column Total – all HIV-Negative Linked to PrEP Provider
Num
5
335
BMSMID_07
Total Number of HIV-Negative MSM/IDU Prescribed PrEP at the STD Clinic
Num
5
Comp C
only
336
BMSM_07
Total Number of HIV-Negative MSM Prescribed PrEP at the STD Clinic
Num
5
Comp C
only
337
BPWID_07
Total Number of HIV-Negative PWID Prescribed PrEP at the STD Clinic
Num
5
Comp C
only
338
BHETM_07
Total Number of HIV-Negative Heterosexual Males Prescribed PrEP at the STD
Clinic
Num
5
Comp C
only
339
BHETF_07
Total Number of HIV-Negative Heterosexual Females Prescribed PrEP at the STD
Clinic
Num
5
Comp C
only
340
BOTHS_07
Total Number of HIV-Negative Other Pop. Prescribed PrEP at the STD Clinic
Num
5
Comp C
only
341
BUNKS_07
Total Number of HIV-Negative Unk Pop. Prescribed PrEP at the STD Clinic
Num
5
Comp C
only
342
BTOT_07 (C)
Column Total – all HIV-Negative Prescribed PrEP at the STD Clinic
Num
5
Table C
343
CLT15_01
Total Number Persons <15 tested for rectal GC/CT
Num
5
Comp C
only
344
C1519_01
Total Number of Persons 15-19 tested for rectal GC/CT
Num
5
Comp C
only
345
C2029_01
Total Number of Persons 20-29 tested for rectal GC/CT
Num
5
Comp C
only
346
C3065_01
Total Number of Persons 30-65 tested for rectal GC/CT
Num
5
Comp C
only
347
C66_01
Total Number of Persons >65 tested for rectal GC/CT
Num
5
Comp C
only
348
CUNK_01
Total Number of Persons of Unknown Age tested for rectal GC/CT
Num
5
Comp C
only
349
CLT15_02
Total Number Persons <15 tested positive for rectal GC/CT
Num
5
Comp C
only
350
C1519_02
Total Number of Persons 15-19 tested positive for rectal GC/CT
Num
5
Comp C
only
351
C2029_02
Total Number of Persons 20-29 tested positive for rectal GC/CT
Num
5
Comp C
only
352
C3065_02
Total Number of Persons 30-65 tested positive for rectal GC/CT
Num
5
Comp C
only
353
C66_02
Total Number of Persons >65 tested positive for rectal GC/CT
Num
5
Comp C
only
354
CUNK_02
Total Number of Persons of Unknown Age tested positive for rectal GC/CT
Num
5
Comp C
only
355
CM_01
Total Number Males tested for rectal GC/CT
Num
5
All
356
CF_01
Total Number of Females tested for rectal GC/CT
Num
5
All
357
CTG_01
Total Number of Transgender tested for rectal GC/CT
Num
5
All
358
CUNKG_01
Total Number of Unk Gender tested for rectal GC/CT
Num
5
All
359
CM_02
Total Number Males tested positive for rectal GC/CT
Num
5
All
360
CF_02
Total Number of Females tested positive for rectal GC/CT
Num
5
All
361
CTG_02
Total Number of Transgender tested positive for rectal GC/CT
Num
5
All
362
CUNKG_02
Total Number of Unk Gender tested positive for rectal GC/CT
Num
5
All
363
CHISP_01
Total Number of Hispanics/Latino tested for rectal GC/CT
Num
5
All
37
Version 8
364
CAIAN_01
Total Number of NH-AIAN tested for rectal GC/CT
Num
5
All
365
CASIAN_01
Total Number of NH-Asian tested for rectal GC/CT
Num
5
All
366
CBLACK_01
Total Number of NH-Black tested for rectal GC/CT
Num
5
All
367
CNHPI_01
Total Number of NH-NHOPI tested for rectal GC/CT
Num
5
All
368
CWHTE_01
Total Number of NH-White tested for rectal GC/CT
Num
5
All
369
CMULT_01
Total Number of NH-Multi-Race tested for rectal GC/CT
Num
5
All
370
CUNKR_01
Total Number of NH-Unk-Race tested for rectal GC/CT
Num
5
All
371
CHISP_02
Total Number of Hispanics/Latino tested positive for rectal GC/CT
Num
5
All
372
CAIAN_02
Total Number of NH-AIAN tested positive for rectal GC/CT
Num
5
All
373
CASIAN_02
Total Number of NH-Asian tested positive for rectal GC/CT
Num
5
All
374
CBLACK_02
Total Number of NH-Black tested positive for rectal GC/CT
Num
5
All
375
CNHPI_02
Total Number of NH-NHOPI tested positive for rectal GC/CT
Num
5
All
376
CWHTE_02
Total Number of NH-White tested positive for rectal GC/CT
Num
5
All
377
CMULT_02
Total Number of NH-Multi-Race tested positive for rectal GC/CT
Num
5
All
378
CUNKR_02
Total Number of NH-Unk-Race tested positive for rectal GC/CT
Num
5
All
379
CMSMID_01
Total Number of MSM/IDU tested for rectal GC/CT
Num
5
Comp C
only
380
CMSM_01
Total Number of MSM tested for rectal GC/CT
Num
5
All
381
CPWID_01
Total Number of PWID tested for rectal GC/CT
Num
5
Comp C
only
382
CHETM_01
Total Number of Heterosexual Males tested for rectal GC/CT
Num
5
Comp C
only
383
CHETF_01
Total Number of Heterosexual Females tested for rectal GC/CT
Num
5
Comp C
only
384
COTHS_01
Total Number of Other Pop. tested for rectal GC/CT
Num
5
Comp C
only
385
CUNKS_01
Total Number of Unk Pop. tested for rectal GC/CT
Num
5
Comp C
only
386
CTOT_01 (C)
Total Number of Persons tested for rectal GC/CT
Num
5
387
CMSMID_02
Total Number of MSM/IDU tested positive for rectal GC/CT
Num
5
Comp C
only
388
CMSM_02
Total Number of MSM tested positive for rectal GC/CT
Num
5
All
389
CPWID_02
Total Number of PWID tested positive for rectal GC/CT
Num
5
Comp C
only
390
CHETM_02
Total Number of Heterosexual Males tested positive for rectal GC/CT
Num
5
Comp C
only
391
CHETF_02
Total Number of Heterosexual Females tested positive for rectal GC/CT
Num
5
Comp C
only
392
COTHS_02
Total Number of Other Pop. tested positive for rectal GC/CT
Num
5
Comp C
only
393
CUNKS_02
Total Number of Unk Pop. tested positive for rectal GC/CT
Num
5
Comp C
only
394
CTOT_02 (C)
Total Number of Persons tested positive for rectal GC/CT
Num
5